Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",A1BG,Alpha-1B-glycoprotein,22268,1588,1.60 [1.20-2.13],0.0012613374551288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AARSD1,Alanyl-tRNA editing protein Aarsd1,25512,1792,1.08 [1.00-1.16],0.04710417810814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABL1,Tyrosine-protein kinase ABL1,25512,1792,1.09 [1.03-1.15],0.0041858459634351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",24989,1767,1.19 [1.13-1.25],8.549658233625385e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,25161,1772,1.46 [1.35-1.57],1.3164647675498208e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,25613,1801,1.14 [1.05-1.23],0.0016776742800087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,21601,1534,0.78 [0.70-0.87],9.514848842735187e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,25701,1811,1.52 [1.35-1.70],1.14800647593199e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,25822,1816,1.14 [1.07-1.22],4.416532422071784e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTA2,"Actin, aortic smooth muscle",25161,1772,1.17 [1.08-1.27],7.426030880627753e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,25403,1773,2.87 [2.49-3.31],1.8712426891599301e-47
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,25613,1801,1.23 [1.16-1.31],6.866781609369033e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,21528,1521,1.18 [1.09-1.29],0.0001231431379081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA,Adenosine deaminase,25921,1826,1.26 [1.13-1.40],1.558300554423112e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA2,Adenosine deaminase 2,25445,1793,1.14 [1.03-1.25],0.0121815177529006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,21601,1534,1.28 [1.12-1.46],0.0002366035362721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,25451,1778,0.82 [0.73-0.92],0.0006135774015271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,25827,1813,1.45 [1.27-1.66],9.439683254501601e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,22149,1572,1.47 [1.25-1.73],2.374202587525785e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,21601,1534,1.22 [1.05-1.43],0.0104385345400905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,25930,1825,0.63 [0.53-0.75],1.7058716441451148e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,25512,1792,1.30 [1.17-1.44],6.796137028726204e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,25161,1772,1.14 [1.02-1.27],0.0224164310703463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,21601,1534,1.30 [1.14-1.47],7.248106932386632e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,25671,1804,0.86 [0.79-0.95],0.0021402331730964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,22235,1580,1.98 [1.74-2.24],5.844219289366918e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,21631,1536,1.64 [1.34-2.01],1.618698742881249e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,21736,1552,1.59 [1.43-1.77],7.191919566486299e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,25724,1819,0.74 [0.64-0.86],4.985992253850904e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,25787,1817,0.75 [0.65-0.86],3.4879538223715483e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRF5,Adhesion G protein-coupled receptor F5,22239,1578,1.32 [1.12-1.54],0.0006247195971548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,25512,1792,1.10 [1.03-1.17],0.0035747559085073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH1B,All-trans-retinol dehydrogenase,21736,1552,1.08 [1.01-1.14],0.0199910628850227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,25161,1772,1.09 [1.04-1.14],0.0007896696182031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,25852,1817,2.90 [2.47-3.41],1.7899983705480763e-38
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,24826,1742,1.16 [1.11-1.21],1.3022412415028178e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR3,Anterior gradient protein 3,24957,1765,1.17 [1.09-1.24],3.1006980183384625e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,25724,1819,1.60 [1.43-1.78],1.827000611119061e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRP,Agouti-related protein,25921,1826,1.15 [1.07-1.24],0.0002111660754819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,25613,1801,1.13 [1.07-1.19],3.757697909250512e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,21631,1536,1.38 [1.21-1.57],9.398022144758086e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1,Allograft inflammatory factor 1,24989,1767,1.11 [1.03-1.21],0.0081703719589724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1L,Allograft inflammatory factor 1-like,21631,1536,1.10 [1.03-1.19],0.0089915998110793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",25465,1791,1.09 [1.05-1.13],1.494623428263624e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B1,Aldo-keto reductase family 1 member B1,24989,1767,1.06 [1.01-1.13],0.0306538909584863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B10,Aldo-keto reductase family 1 member B10,21624,1545,1.14 [1.06-1.23],0.0006930486107144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1C4,Aldo-keto reductase family 1 member C4,25161,1772,1.12 [1.05-1.20],0.0009283490250896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR7L,Aflatoxin B1 aldehyde reductase member 4,21601,1534,1.10 [1.03-1.18],0.0062097567269048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALCAM,CD166 antigen,25930,1825,1.31 [1.07-1.61],0.0094208357771557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH1A1,Retinal dehydrogenase 1,25606,1800,1.09 [1.01-1.17],0.0267817003912046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",25565,1803,1.27 [1.21-1.33],2.0333641102304194e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",22205,1573,1.14 [1.03-1.26],0.0105547689620296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALMS1,Alstrom syndrome protein 1,21824,1552,1.12 [1.01-1.25],0.0365879982835545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",25512,1792,1.21 [1.18-1.25],4.5459033090739846e-39
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBN,Ameloblastin,25143,1785,0.76 [0.64-0.90],0.0011325883731559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,25820,1812,2.04 [1.65-2.53],8.04750675695557e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO1,Amphoterin-induced protein 1,21624,1545,0.87 [0.78-0.96],0.0073117736052469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO2,Amphoterin-induced protein 2,25512,1792,1.25 [1.05-1.50],0.0129564611017402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMN,Protein amnionless,25143,1785,1.15 [1.06-1.25],0.0012232516066989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOT,Angiomotin,21736,1552,0.83 [0.74-0.94],0.0030862724271229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,20872,1480,0.87 [0.79-0.97],0.0086160909979559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2A,Pancreatic alpha-amylase,24656,1740,0.87 [0.80-0.95],0.0021111422189371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2B,Alpha-amylase 2B,23878,1688,0.87 [0.80-0.96],0.0032004868468588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANG,Angiogenin,25522,1799,1.41 [1.25-1.58],1.3370230422133789e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT1,Angiopoietin-1,25541,1805,1.08 [1.02-1.13],0.0034859182052381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,25852,1817,1.62 [1.46-1.80],7.846046901538193e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,25231,1775,1.40 [1.22-1.62],2.2272295719699923e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,25614,1807,1.39 [1.24-1.55],2.133364572071052e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,25685,1817,1.30 [1.19-1.43],7.081478264944514e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,25852,1817,1.25 [1.12-1.39],4.704383607196939e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANPEP,Aminopeptidase N,25644,1806,1.47 [1.27-1.71],2.0637457736493241e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,25026,1760,1.22 [1.16-1.28],3.7860686261847495e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA2,Annexin A2,21320,1516,1.12 [1.05-1.19],0.0004072008198331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA5,Annexin A5,24944,1750,1.21 [1.04-1.40],0.0127494247328606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC3,Membrane primary amine oxidase,25691,1811,1.37 [1.19-1.57],9.174702558177434e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP1G2,AP-1 complex subunit gamma-like 2,22130,1568,1.08 [1.02-1.15],0.0072759593502291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APCS,Serum amyloid P-component,22085,1574,1.49 [1.29-1.72],3.3607102352115134e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,25784,1815,1.10 [1.03-1.18],0.0040398241324197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,25613,1801,0.72 [0.66-0.78],2.3009491827954696e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA4,Apolipoprotein A-IV,22268,1588,1.15 [1.01-1.31],0.0319897618080311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOF,Apolipoprotein F,22256,1575,0.78 [0.67-0.92],0.0030783854093082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APP,Amyloid-beta precursor protein,25557,1794,1.11 [1.05-1.18],0.0005485751645516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,25512,1792,1.49 [1.37-1.62],3.591397415503172e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF1,Rho guanine nucleotide exchange factor 1,22173,1569,1.06 [1.00-1.11],0.0471995166175046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL13B,ADP-ribosylation factor-like protein 13B,21528,1521,1.08 [1.01-1.15],0.0303354196225223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSA,Arylsulfatase A,25606,1800,1.15 [1.05-1.26],0.0025884342309446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSB,Arylsulfatase B,25512,1792,1.12 [1.04-1.21],0.0018902788063543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,25691,1811,0.87 [0.77-0.98],0.0196842858987878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH1,Acid ceramidase,22051,1566,1.17 [1.06-1.29],0.0016975125271425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,25451,1778,2.17 [1.91-2.46],1.1421805144387797e-33
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,22256,1575,1.81 [1.51-2.16],6.110328673805725e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATF2,Cyclic AMP-dependent transcription factor ATF-2,25026,1760,0.93 [0.87-0.99],0.0211648060077975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATF4,Cyclic AMP-dependent transcription factor ATF-4,21457,1520,0.82 [0.71-0.95],0.0087888265540707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATOX1,Copper transport protein ATOX1,25671,1804,1.10 [1.04-1.16],0.0018188881429338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,22149,1572,1.23 [1.05-1.44],0.0098623242802095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXIN1,Axin-1,25598,1805,1.05 [1.00-1.09],0.0385182244212412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,25691,1811,0.80 [0.69-0.94],0.0050171382595645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZU1,Azurocidin,24824,1741,1.07 [1.02-1.12],0.0053141737085177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,22268,1588,1.39 [1.30-1.49],6.628938053120077e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",21631,1536,1.66 [1.46-1.89],2.6683684425810524e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",25724,1819,1.41 [1.22-1.63],3.7940673268761727e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BACH1,Transcription regulator protein BACH1,25598,1805,1.10 [1.04-1.16],0.0010646309785495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG3,BAG family molecular chaperone regulator 3,25403,1773,1.12 [1.00-1.25],0.0430074939847728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,24989,1767,1.30 [1.22-1.38],3.5909938881084496e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,24989,1767,1.30 [1.12-1.49],0.0003368028274137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BANK1,B-cell scaffold protein with ankyrin repeats,25598,1805,1.04 [1.00-1.08],0.0494878550409368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAP18,Chromatin complexes subunit BAP18,22173,1569,1.09 [1.03-1.16],0.00466068922727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAX,Apoptosis regulator BAX,24982,1755,1.08 [1.03-1.13],0.0016673399528403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAM,Basal cell adhesion molecule,25606,1800,1.21 [1.02-1.45],0.0324582084027202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,25451,1778,0.54 [0.48-0.61],6.849503096272541e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",22239,1578,1.24 [1.07-1.44],0.0041499173220658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2,Apoptosis regulator Bcl-2,22149,1572,1.11 [1.02-1.22],0.0216517992135255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",25598,1805,1.30 [1.17-1.44],7.254845796737355e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L15,Bcl-2-like protein 15,21601,1534,1.08 [1.01-1.16],0.0263097115314241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCR,Breakpoint cluster region protein,25598,1805,1.05 [1.01-1.10],0.0275936026754427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BDNF,Brain-derived neurotrophic factor,22235,1580,1.10 [1.04-1.17],0.0013963297253938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGN,Biglycan,24955,1762,0.94 [0.91-0.98],0.0014247205317526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BID,BH3-interacting domain death agonist,25598,1805,1.06 [1.00-1.13],0.0398859054814186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLMH,Bleomycin hydrolase,25930,1825,0.87 [0.77-0.98],0.0242356848128976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLNK,B-cell linker protein,21601,1534,1.17 [1.05-1.31],0.0047274760777408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,21736,1552,2.11 [1.77-2.52],9.16088325266411e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,21601,1534,1.17 [1.05-1.30],0.0032979602939572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOLA1,BolA-like protein 1,21521,1528,1.10 [1.02-1.20],0.0161944645247767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFA2,BPI fold-containing family A member 2,20858,1477,0.93 [0.88-0.97],0.0022425026836553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,25564,1803,1.43 [1.33-1.53],1.7380536273116212e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD1,Bromodomain-containing protein 1,21824,1552,0.78 [0.66-0.92],0.0035113649850809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRK1,Protein BRICK1,25026,1760,1.12 [1.02-1.23],0.0159757929573901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,25873,1818,2.96 [2.44-3.60],4.614228146215471e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,25866,1814,1.42 [1.34-1.51],2.5843548017639973e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTC,Probetacellulin,24989,1767,1.07 [1.01-1.13],0.018214647650245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,25724,1819,1.58 [1.35-1.85],1.2173019356117897e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,25598,1805,1.32 [1.18-1.48],2.43710353965269e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C19orf12,Protein C19orf12,25026,1760,1.12 [1.06-1.18],9.302155667865366e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,25691,1811,1.22 [1.12-1.34],1.266151340723499e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,21695,1548,0.84 [0.77-0.93],0.0004436006626043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,21754,1545,1.45 [1.24-1.69],2.743358486654313e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7orf50,Uncharacterized protein C7orf50,22173,1569,1.26 [1.07-1.50],0.0067436634079472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C8B,Complement component C8 beta chain,22268,1588,1.19 [1.02-1.39],0.0282860229431488
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA12,Carbonic anhydrase 12,25512,1792,1.18 [1.04-1.34],0.0091578968712186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,25852,1817,0.66 [0.58-0.74],7.1390016916601885e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,25930,1825,1.89 [1.60-2.23],4.549171756589685e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",25161,1772,1.13 [1.08-1.18],1.8075192750823849e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,25519,1799,0.77 [0.72-0.82],1.0708270149029991e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA8,Carbonic anhydrase-related protein,21601,1534,0.81 [0.66-0.99],0.0414424875479092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA9,Carbonic anhydrase 9,25852,1817,1.19 [1.08-1.31],0.0005615998393262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,25405,1777,1.14 [1.07-1.21],1.4670585529979893e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCB,Calcitonin gene-related peptide 2,22173,1569,1.22 [1.08-1.38],0.0011527252592935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,24989,1767,1.10 [1.01-1.21],0.0355345789692932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,25548,1793,1.85 [1.51-2.26],3.880785371228863e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPG,Macrophage-capping protein,25452,1795,1.18 [1.11-1.25],1.1741473650573018e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP4,Caspase-4,21824,1552,1.04 [1.01-1.07],0.0079660594728689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,25581,1799,1.08 [1.01-1.14],0.0162820457380283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,25852,1817,0.64 [0.56-0.73],1.0472824260376977e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBS,Cystathionine beta-synthase,21631,1536,1.12 [1.02-1.22],0.0223287299122982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,25451,1778,1.07 [1.02-1.13],0.0117341090671988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,25613,1801,1.61 [1.42-1.82],2.6476303290545705e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL11,Eotaxin,25921,1826,1.45 [1.30-1.61],1.2806238469469454e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL14,C-C motif chemokine 14,25522,1799,1.21 [1.10-1.33],4.6252530213244224e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,25930,1825,1.29 [1.18-1.41],1.379996587177845e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,25930,1825,1.29 [1.19-1.39],1.1014936243835664e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,25547,1809,1.20 [1.15-1.25],7.957865139697313e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL18,C-C motif chemokine 18,25245,1784,1.11 [1.05-1.17],9.51221631143044e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL19,C-C motif chemokine 19,25866,1814,1.07 [1.04-1.10],6.648334568366179e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL2,C-C motif chemokine 2,25403,1773,1.11 [1.02-1.19],0.0101522241287951
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,25921,1826,1.22 [1.17-1.28],5.804293973745334e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,25724,1819,1.44 [1.33-1.56],6.110760906529706e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,25323,1796,1.47 [1.37-1.58],4.1220913028488735e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL23,C-C motif chemokine 23,25724,1819,1.25 [1.14-1.37],4.831280274012506e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL24,C-C motif chemokine 24,25685,1817,1.06 [1.01-1.12],0.0185821382094023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL25,C-C motif chemokine 25,25921,1826,1.27 [1.17-1.38],8.278282193235579e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL27,C-C motif chemokine 27,25613,1801,1.20 [1.12-1.28],1.0161623745182933e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,25525,1800,1.21 [1.14-1.29],1.313084572050544e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL3,C-C motif chemokine 3,25598,1805,1.12 [1.06-1.18],1.4062969746078786e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL4,C-C motif chemokine 4,25633,1812,1.08 [1.02-1.14],0.005546138909079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL5,C-C motif chemokine 5,25691,1811,1.11 [1.07-1.16],8.481488116144052e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,25598,1805,1.29 [1.20-1.38],8.908330985430206e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL8,C-C motif chemokine 8,25820,1812,1.08 [1.01-1.16],0.0176617757758515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN1,CCN family member 1,25477,1787,1.17 [1.11-1.23],2.6481487333558445e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN2,CCN family member 2,25615,1815,1.11 [1.04-1.19],0.0031278532842387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,25886,1822,1.50 [1.33-1.70],9.042951180223339e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN4,CCN family member 4,25852,1817,1.25 [1.12-1.39],3.713321855847716e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD101,Immunoglobulin superfamily member 2,22149,1572,1.42 [1.26-1.61],2.4360708455673032e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,25047,1768,1.63 [1.48-1.79],6.124223616648537e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,25691,1811,1.25 [1.14-1.37],2.626785914440647e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD200R1,Cell surface glycoprotein CD200 receptor 1,25504,1802,0.87 [0.77-0.98],0.0266236402078202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD207,C-type lectin domain family 4 member K,25084,1768,1.37 [1.24-1.53],3.743299166271407e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD248,Endosialin,22235,1580,0.78 [0.70-0.87],5.160820030832353e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,25671,1804,1.53 [1.38-1.69],8.163746320930904e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,25451,1778,1.45 [1.28-1.64],2.8515229236547477e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD276,CD276 antigen,25593,1813,1.29 [1.15-1.45],1.9215064459130675e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD2AP,CD2-associated protein,25613,1801,1.09 [1.02-1.16],0.0079332805784506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300A,CMRF35-like molecule 8,21736,1552,1.51 [1.28-1.78],9.057635583230856e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,25866,1814,1.48 [1.32-1.66],3.3886475395019474e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,25773,1810,1.49 [1.35-1.65],2.951091864349965e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LF,CMRF35-like molecule 1,25852,1817,1.27 [1.19-1.37],2.6394687332916108e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,25512,1792,1.87 [1.64-2.12],1.06848551337385e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD33,Myeloid cell surface antigen CD33,25671,1804,1.07 [1.02-1.13],0.0100089342523748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD36,Platelet glycoprotein 4,21601,1534,1.11 [1.00-1.23],0.0411465648556051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,25558,1802,1.52 [1.33-1.73],4.970538083682384e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,25594,1810,1.17 [1.09-1.27],6.329698749024161e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40LG,CD40 ligand,25921,1826,1.09 [1.04-1.15],0.0009837588831075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD46,Membrane cofactor protein,25436,1792,1.45 [1.26-1.65],6.88926701005838e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD48,CD48 antigen,25685,1817,1.20 [1.05-1.39],0.0098441871955982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5,T-cell surface glycoprotein CD5,25820,1812,1.40 [1.25-1.57],1.1013891628357661e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD55,Complement decay-accelerating factor,24702,1743,1.41 [1.22-1.62],2.9954077169715787e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,24640,1727,1.74 [1.44-2.11],9.197502004358725e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD6,T-cell differentiation antigen CD6,25873,1818,1.11 [1.03-1.19],0.0079819554093681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD63,CD63 antigen,25403,1773,1.09 [1.00-1.18],0.047416461870645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD7,T-cell antigen CD7,21567,1533,1.22 [1.09-1.38],0.0008805122822628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD70,CD70 antigen,25598,1805,1.24 [1.13-1.37],1.1578011173327454e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,25866,1814,1.57 [1.40-1.76],3.5808766300044005e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,25921,1826,1.17 [1.06-1.28],0.0013734851866069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,22239,1578,1.57 [1.37-1.81],1.9689057606086558e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,25598,1805,2.09 [1.89-2.31],3.3511672727283115e-47
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD93,Complement component C1q receptor,24618,1737,1.34 [1.17-1.53],2.100050002852142e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99,CD99 antigen,25606,1800,1.35 [1.09-1.67],0.0055832750699941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,25606,1800,1.89 [1.60-2.23],5.880633486164917e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC27,Cell division cycle protein 27 homolog,24989,1767,1.11 [1.04-1.19],0.0016892598471368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,25451,1778,1.57 [1.47-1.69],5.938540868217194e-38
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH1,Cadherin-1,24730,1740,1.23 [1.13-1.34],2.116485622805206e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,25613,1801,1.39 [1.24-1.56],1.4034708965441024e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH23,Cadherin-23,22173,1569,0.72 [0.59-0.87],0.0010118116192776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH5,Cadherin-5,25930,1825,0.84 [0.73-0.97],0.017649043438054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR1,Cadherin-related family member 1,25026,1760,0.89 [0.80-0.99],0.0316473047481562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,25512,1792,1.16 [1.09-1.23],1.2545744722431198e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKL5,Cyclin-dependent kinase-like 5,21521,1528,0.88 [0.80-0.98],0.0228806075633399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKN1A,Cyclin-dependent kinase inhibitor 1,25512,1792,1.05 [1.01-1.09],0.0108672697233133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,25638,1816,1.19 [1.02-1.39],0.0279693548430539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,25634,1801,1.83 [1.52-2.19],6.568872445778399e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,22149,1572,0.76 [0.72-0.80],1.401264942621586e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,21824,1552,1.11 [1.00-1.22],0.0425979221216206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,24989,1767,1.11 [1.02-1.21],0.0190094156875236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,24651,1741,1.52 [1.44-1.61],1.5396860784287623e-53
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,22235,1580,1.51 [1.39-1.64],5.776668089809885e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,25161,1772,1.26 [1.17-1.36],4.82835669903631e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,22235,1580,1.09 [1.01-1.17],0.0306815403917354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEND1,Cell cycle exit and neuronal differentiation protein 1,21521,1528,1.10 [1.01-1.19],0.0323368452754874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP43,Centrosomal protein 43,24961,1756,1.07 [1.00-1.13],0.0376544667463935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES1,Liver carboxylesterase 1,25657,1810,1.14 [1.09-1.19],9.97337278798527e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES2,Cocaine esterase,25512,1792,1.23 [1.15-1.32],7.599037133503107e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN2,Centrin-2,25026,1760,1.08 [1.02-1.15],0.0118670088420395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFB,Complement factor B,21863,1559,1.56 [1.35-1.81],3.219819104359387e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFD,Complement factor D,22268,1588,1.50 [1.26-1.80],9.543653199816935e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFH,Complement factor H,21001,1506,1.73 [1.41-2.13],2.435387115361691e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR5,Complement factor H-related protein 5,21980,1562,1.23 [1.09-1.38],0.0006528911800449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFI,Complement factor I,22268,1588,2.42 [1.91-3.07],2.774030765408063e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGA,Glycoprotein hormones alpha chain,25606,1800,1.10 [1.04-1.16],0.0003279356601439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGN,Cingulin,21624,1545,1.18 [1.05-1.32],0.0054637082205537
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,25613,1801,1.36 [1.23-1.49],2.774170808081811e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,24989,1767,1.09 [1.02-1.16],0.0115788610637059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",22173,1569,1.71 [1.54-1.90],2.2379839905239905e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,22130,1568,1.56 [1.35-1.80],2.435579900176e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,22235,1580,1.22 [1.16-1.29],2.987766037180041e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,24999,1762,1.38 [1.32-1.44],4.958686878086734e-48
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,25685,1817,1.54 [1.36-1.76],3.5273535775662204e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,22235,1580,1.25 [1.15-1.36],2.712607179002412e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,25782,1811,1.90 [1.70-2.13],1.5794060026398754e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,22235,1580,1.29 [1.19-1.39],5.39523370705631e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",25501,1805,1.11 [1.04-1.18],0.0012950963012834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,25451,1778,1.49 [1.33-1.68],1.335052744282264e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,25606,1800,1.62 [1.43-1.84],1.1639828886800745e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,25161,1772,1.30 [1.14-1.48],6.51484459678435e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1B,C-type lectin domain family 1 member B,25866,1814,1.06 [1.02-1.11],0.0050622636096057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC2L,C-type lectin domain family 2 member L,21624,1545,0.87 [0.77-0.98],0.0239755084857733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,21763,1552,0.64 [0.51-0.81],0.0001593972003593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,25598,1805,0.78 [0.69-0.88],2.61915320940245e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,25598,1805,1.34 [1.26-1.41],7.393833834186975e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,25520,1793,1.97 [1.75-2.21],1.6100099771442665e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,24989,1767,1.32 [1.22-1.44],2.559160927542397e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,25921,1826,1.25 [1.16-1.35],2.7310613853148788e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,21624,1545,1.37 [1.23-1.52],5.313174171541848e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,25852,1817,1.78 [1.46-2.16],9.094600506267713e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPS,Colipase,25572,1798,0.93 [0.87-0.98],0.0124836187979727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,25921,1826,1.26 [1.14-1.39],4.047152899933047e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN3,Calsyntenin-3,22173,1569,1.19 [1.03-1.38],0.0209437149129717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLUL1,Clusterin-like protein 1,25568,1799,0.88 [0.80-0.96],0.0046952291311534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,25691,1811,0.91 [0.83-0.99],0.0317937936675241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,25930,1825,0.59 [0.50-0.68],1.5958488096223396e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN3,Contactin-3,25606,1800,0.84 [0.74-0.95],0.0063198808623442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN4,Contactin-4,25606,1800,0.75 [0.63-0.90],0.0019130938446104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,25691,1805,0.71 [0.63-0.79],5.532345950266879e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COCH,Cochlin,22239,1578,1.25 [1.13-1.37],1.0562440353044835e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,25696,1811,2.32 [1.93-2.79],3.174126970966882e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL24A1,Collagen alpha-1(XXIV) chain,22149,1572,1.10 [1.01-1.20],0.02997774408189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL28A1,Collagen alpha-1(XXVIII) chain,21624,1545,0.91 [0.85-0.97],0.0029859926196924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,25613,1801,1.24 [1.11-1.38],9.819483105009604e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL5A1,Collagen alpha-1(V) chain,21736,1552,1.28 [1.13-1.44],5.8881915037066254e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,25930,1825,1.77 [1.57-1.99],3.7982360098518925e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,25598,1805,1.12 [1.02-1.24],0.0199124865611971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,25593,1813,2.09 [1.79-2.44],1.869816811922229e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMMD9,COMM domain-containing protein 9,22130,1568,0.88 [0.78-0.98],0.0255963524608198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMT,Catechol O-methyltransferase,24884,1758,1.08 [1.02-1.13],0.0043517190133294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",21631,1536,1.23 [1.11-1.37],9.040388987852338e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO1A,Coronin-1A,25096,1764,1.06 [1.02-1.11],0.0075665688526167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",25512,1792,1.11 [1.04-1.17],0.0008267048425367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA1,Carboxypeptidase A1,25930,1825,1.15 [1.09-1.23],2.2823060792208967e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA4,Carboxypeptidase A4,21305,1522,0.84 [0.75-0.95],0.0035353977732823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB1,Carboxypeptidase B,25930,1825,1.12 [1.05-1.19],0.0003086509896931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,25747,1804,1.51 [1.35-1.70],4.152725140462666e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",21601,1534,1.22 [1.01-1.46],0.0362027329136382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPPED1,Serine/threonine-protein phosphatase CPPED1,25866,1814,1.08 [1.01-1.15],0.0157571262160593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPQ,Carboxypeptidase Q,22201,1577,1.34 [1.17-1.52],1.544297882905822e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,25802,1812,1.21 [1.09-1.34],0.0004242659889828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM1,Probable carboxypeptidase X1,25671,1804,1.13 [1.06-1.19],5.571548582959776e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,22239,1578,1.38 [1.14-1.67],0.0008943172587664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR2,Complement receptor type 2,25691,1811,0.84 [0.77-0.92],0.0002269937399613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREBZF,CREB/ATF bZIP transcription factor,21457,1520,0.76 [0.62-0.93],0.0064250815083677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,25257,1778,1.40 [1.28-1.54],1.6551267618287494e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,21736,1552,1.45 [1.27-1.65],2.229565485787452e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,25685,1817,1.17 [1.08-1.27],0.0001085752664106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,25593,1813,1.43 [1.23-1.65],2.6244774729708684e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,25724,1819,1.44 [1.17-1.77],0.0006920894390482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIP2,Cysteine-rich protein 2,25451,1778,1.42 [1.27-1.57],1.08122096215203e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,25852,1817,0.88 [0.83-0.94],0.0002667506254024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,22041,1552,0.76 [0.64-0.91],0.0029108172550824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRLF1,Cytokine receptor-like factor 1,25724,1819,1.25 [1.07-1.45],0.0055557626631101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAP,Cartilage-associated protein,21624,1545,0.86 [0.76-0.97],0.0183021112134421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB2,Beta-crystallin B2,22173,1569,1.09 [1.00-1.19],0.0417379548638862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,25724,1819,1.64 [1.42-1.89],9.324522444991434e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,25451,1778,1.14 [1.06-1.23],0.0002030981192859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3R,Granulocyte colony-stimulating factor receptor,21601,1534,1.20 [1.03-1.39],0.0175364573778822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,22235,1580,0.76 [0.67-0.87],4.7832054315205e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSRP3,Cysteine and glycine-rich protein 3,21528,1521,1.07 [1.01-1.12],0.012142962216627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST1,Cystatin-SN,19268,1372,0.92 [0.87-0.97],0.0021992307049688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,25650,1808,2.14 [1.87-2.46],5.6278008065559825e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST6,Cystatin-M,24940,1759,0.90 [0.82-0.98],0.0176909953943581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST7,Cystatin-F,25633,1812,1.12 [1.08-1.17],2.4715978618808797e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,25248,1774,1.37 [1.25-1.51],6.001486516889465e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTBS,Di-N-acetylchitobiase,21955,1560,1.31 [1.09-1.57],0.0039546090077095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,22235,1580,1.55 [1.31-1.83],2.3378683818169605e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRB1,Chymotrypsinogen B,25606,1800,1.08 [1.00-1.16],0.0451133492338904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRC,Chymotrypsin-C,25592,1814,0.88 [0.82-0.94],0.0001135357505298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,22173,1569,0.91 [0.85-0.97],0.0050092476809549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSB,Cathepsin B,25611,1804,1.11 [1.03-1.20],0.0102722620245716
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSC,Dipeptidyl peptidase 1,25549,1812,1.18 [1.07-1.30],0.0006048816173147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,23871,1690,1.72 [1.60-1.85],7.457083056886187e-46
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSF,Cathepsin F,25671,1804,1.29 [1.17-1.42],4.253136862934137e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSH,Pro-cathepsin H,25083,1769,1.11 [1.05-1.18],0.0002272664782783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,25613,1801,1.73 [1.47-2.03],3.956476761565119e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSO,Cathepsin O,25921,1826,1.36 [1.20-1.53],1.36832196577871e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSS,Cathepsin S,20235,1435,1.47 [1.20-1.81],0.0002475184993812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSV,Cathepsin L2,25766,1809,0.90 [0.81-0.99],0.0310222668745606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,25593,1803,1.64 [1.44-1.86],3.4589773749802866e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,25598,1805,1.42 [1.32-1.52],1.7364333906573006e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL11,C-X-C motif chemokine 11,25866,1814,1.06 [1.01-1.11],0.029976247981447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL12,Stromal cell-derived factor 1,25143,1785,1.29 [1.16-1.42],1.2909179710785753e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL13,C-X-C motif chemokine 13,25866,1814,1.13 [1.06-1.21],0.0004118590094213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL14,C-X-C motif chemokine 14,25143,1785,1.12 [1.05-1.19],0.0003461358002804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,25880,1821,2.40 [2.02-2.85],1.924036214825781e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,25921,1826,1.70 [1.59-1.81],2.8907896827785606e-60
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL5,C-X-C motif chemokine 5,25524,1795,1.06 [1.02-1.10],0.0016350608728033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,25416,1805,1.18 [1.11-1.24],8.847320524408241e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,25724,1819,1.14 [1.07-1.21],4.719120226788484e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,21883,1549,1.11 [1.03-1.20],0.0075903333489265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTL1,Cytokine-like protein 1,22235,1580,1.38 [1.13-1.69],0.0016585940744127
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAG1,Dystroglycan,25724,1819,1.14 [1.05-1.24],0.0027734632010193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBI,Acyl-CoA-binding protein,25479,1793,1.08 [1.03-1.14],0.0025803262677079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",25671,1804,1.28 [1.14-1.45],3.175550852773879e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCC,Netrin receptor DCC,21624,1545,0.75 [0.60-0.94],0.0115074749667836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCUN1D1,DCN1-like protein 1,21521,1528,0.92 [0.85-0.99],0.0306850824202059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",25512,1792,1.33 [1.22-1.45],3.1611000561117965e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,25866,1814,1.81 [1.53-2.13],1.5644589597193593e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDT,D-dopachrome decarboxylase,22235,1580,1.13 [1.01-1.26],0.0279590425770583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",25598,1805,1.09 [1.04-1.13],0.0001782666543595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,25069,1770,1.13 [1.05-1.22],0.0006943126512634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,25243,1777,1.10 [1.07-1.13],4.578402844183256e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DFFA,DNA fragmentation factor subunit alpha,25921,1826,1.08 [1.01-1.14],0.01623440180538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGKA,Diacylglycerol kinase alpha,21601,1534,1.10 [1.01-1.21],0.0267709061415963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK1,Dickkopf-related protein 1,25866,1814,1.10 [1.03-1.18],0.00377966663503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKKL1,Dickkopf-like protein 1,25512,1792,0.94 [0.90-0.99],0.0191387486629722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLK1,Protein delta homolog 1,25930,1825,0.89 [0.83-0.96],0.0017311540392003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,25671,1804,1.48 [1.29-1.69],1.2044875283392696e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL4,Delta-like protein 4,21631,1536,1.06 [1.01-1.11],0.0124885216921642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,21631,1536,0.85 [0.79-0.92],6.133684956863889e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB1,DnaJ homolog subfamily B member 1,25512,1792,1.06 [1.01-1.11],0.0152089746545804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,25554,1811,0.75 [0.64-0.88],0.0004366222876139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNLZ,DNL-type zinc finger protein,21521,1528,0.92 [0.86-0.98],0.0083755837141321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM3,Dynamin-3,22205,1573,1.16 [1.07-1.26],0.0005591702764416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNMBP,Dynamin-binding protein,25451,1778,1.10 [1.03-1.17],0.0047359180938956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK2,Docking protein 2,25613,1801,1.04 [1.00-1.07],0.0293166293806987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP1,Dipeptidase 1,25405,1777,0.88 [0.81-0.96],0.0031488173908719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,25598,1805,1.51 [1.37-1.66],2.990783683003136e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,25512,1792,0.55 [0.49-0.62],2.0692116905646297e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,25395,1787,1.24 [1.16-1.32],4.786065763363881e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,25784,1815,1.18 [1.12-1.26],3.2971715056666164e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSC2,Desmocollin-2,25291,1790,1.23 [1.09-1.39],0.0009937528508258
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSCAM,Down syndrome cell adhesion molecule,22205,1573,0.86 [0.75-0.98],0.0219871895905516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG2,Desmoglein-2,25606,1800,0.73 [0.63-0.86],8.841109670285345e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG3,Desmoglein-3,25774,1813,0.84 [0.74-0.95],0.0056680874673384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,22093,1567,1.22 [1.10-1.34],0.0001491368624467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX2,Probable E3 ubiquitin-protein ligase DTX2,21624,1545,0.90 [0.83-0.98],0.0138589780843078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,25512,1792,1.60 [1.38-1.86],4.0377909431712847e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,22130,1568,0.89 [0.80-1.00],0.0462229103317704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",22239,1578,1.18 [1.12-1.25],3.253401311829777e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",21631,1536,1.13 [1.07-1.19],2.3740629081619946e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECI2,Enoyl-CoA delta isomerase 2,21528,1521,1.10 [1.02-1.18],0.0084109817805467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,25852,1817,1.50 [1.34-1.68],1.3127342759430504e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,25598,1805,0.92 [0.88-0.97],0.0004567084575884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,25161,1772,1.72 [1.58-1.89],1.2311416267935992e-32
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,21631,1536,2.40 [2.04-2.81],7.85253287461795e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EEF1D,Elongation factor 1-delta,22239,1578,1.06 [1.01-1.11],0.0206138944840996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,22149,1572,1.53 [1.29-1.81],8.358863934074415e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,25642,1807,1.49 [1.31-1.69],2.043871552686602e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFHD1,EF-hand domain-containing protein D1,22205,1573,1.19 [1.05-1.35],0.0062960156010487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,25559,1796,1.78 [1.55-2.06],2.546012569012436e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,25403,1773,1.81 [1.60-2.05],6.6211292805581066e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGF,Pro-epidermal growth factor,25551,1810,1.04 [1.00-1.09],0.03877425729092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,24989,1767,1.29 [1.17-1.42],4.717047930322688e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFLAM,Pikachurin,22149,1572,1.23 [1.06-1.43],0.0061313474936504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,25930,1825,0.39 [0.31-0.51],3.8504293814366266e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,25598,1805,1.15 [1.09-1.22],1.7588359488089446e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",22080,1564,1.06 [1.01-1.10],0.0105737866289111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,25613,1801,1.13 [1.06-1.20],9.631911126711906e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,25921,1826,1.07 [1.02-1.11],0.0033267965321212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,22239,1578,1.66 [1.44-1.90],1.023700894339405e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOA,Elongin-A,25512,1792,1.10 [1.04-1.17],0.0022080753581016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENAH,Protein enabled homolog,25143,1785,1.21 [1.11-1.32],1.3199821983548832e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,20523,1430,0.84 [0.76-0.94],0.0013402757227269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENG,Endoglin,25930,1825,1.74 [1.35-2.23],1.478780143457497e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENOPH1,Enolase-phosphatase E1,22130,1568,0.87 [0.79-0.96],0.0066892752789944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,25724,1819,0.81 [0.74-0.87],1.412429116460999e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,24876,1757,1.18 [1.13-1.24],5.364274892856662e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,24989,1767,1.12 [1.02-1.24],0.016102065172057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,25161,1772,1.26 [1.08-1.48],0.0040127256720005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTR1,Endosome-associated-trafficking regulator 1,21631,1536,1.08 [1.00-1.16],0.0394704169212686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA1,Ephrin type-A receptor 1,25676,1817,1.23 [1.09-1.39],0.0009817934374692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,24711,1732,1.66 [1.45-1.90],1.7573577181097032e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA4,Ephrin type-A receptor 4,21736,1552,0.79 [0.67-0.94],0.0086461345187218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,25930,1825,1.63 [1.40-1.90],4.4575392330646055e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPPK1,Epiplakin,21631,1536,1.13 [1.07-1.20],8.963003518332046e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,25814,1816,1.51 [1.32-1.71],7.262121406665793e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,25671,1804,1.64 [1.40-1.93],1.4987954647021895e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB3,Receptor tyrosine-protein kinase erbB-3,25499,1807,1.39 [1.13-1.71],0.0017533331654617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EREG,Proepiregulin,25405,1777,1.06 [1.01-1.11],0.0292439658838143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERI1,3'-5' exoribonuclease 1,21824,1552,1.30 [1.15-1.47],3.078782249859911e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERP44,Endoplasmic reticulum resident protein 44,25477,1787,1.18 [1.01-1.38],0.0388247364182944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,25930,1825,1.33 [1.17-1.50],9.7831306716645e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESM1,Endothelial cell-specific molecule 1,25593,1813,0.88 [0.78-0.99],0.0356020989177418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXTL1,Exostosin-like 1,21528,1521,0.86 [0.77-0.96],0.0088048582826009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EZR,Ezrin,25866,1814,1.58 [1.35-1.84],5.195316419431821e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F10,Coagulation factor X,22256,1575,1.33 [1.08-1.63],0.006095341410097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11R,Junctional adhesion molecule A,25606,1800,1.13 [1.05-1.22],0.0007169534501422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F13B,Coagulation factor XIII B chain,22149,1582,1.49 [1.25-1.79],1.4323123015609208e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2R,Proteinase-activated receptor 1,25685,1817,1.10 [1.03-1.18],0.0059361684929184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F7,Coagulation factor VII,25648,1807,1.34 [1.16-1.54],4.460581470303554e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,25658,1809,2.36 [1.88-2.97],1.880717459495124e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",25593,1813,1.19 [1.14-1.23],7.461310680530845e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",25613,1801,1.10 [1.04-1.15],0.0001862873366778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",22239,1578,1.37 [1.26-1.50],2.797488736595943e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",25930,1825,1.41 [1.30-1.53],1.357280987482083e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP5,Fatty acid-binding protein 5,25791,1811,1.16 [1.10-1.23],3.593767950829285e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171A2,Protein FAM171A2,22205,1573,1.03 [1.00-1.07],0.0365549482528633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,22239,1578,2.30 [1.97-2.70],4.717264932947559e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3B,Protein FAM3B,25512,1792,1.37 [1.22-1.55],1.837400506692344e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,25581,1799,1.67 [1.45-1.92],6.250148931413508e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3D,Protein FAM3D,22149,1572,1.09 [1.03-1.16],0.002812803759123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAP,Prolyl endopeptidase FAP,25930,1825,0.76 [0.66-0.88],0.0003255175732917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,25837,1817,1.28 [1.14-1.43],1.740276452473205e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,25921,1826,0.70 [0.63-0.78],2.5516869229204363e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",25613,1801,1.15 [1.09-1.22],7.14539400233314e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,25598,1805,1.24 [1.13-1.35],1.8676737967103413e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,22205,1573,1.24 [1.00-1.52],0.0450644511780727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,25611,1803,1.09 [1.00-1.18],0.0448971401899376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN1,Ficolin-1,22221,1575,1.31 [1.20-1.43],2.9842576996878033e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN2,Ficolin-2,25484,1803,1.19 [1.07-1.33],0.0015629628968072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL6,Fc receptor-like protein 6,25598,1805,0.93 [0.88-0.99],0.0224409030208671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,24989,1767,1.19 [1.11-1.28],1.7193331953410644e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGA,Fibrinogen alpha chain,21742,1550,1.42 [1.21-1.66],1.0023452419541624e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF19,Fibroblast growth factor 19,25724,1819,1.11 [1.05-1.17],0.0001504092193849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF2,Fibroblast growth factor 2,25598,1805,1.12 [1.06-1.19],0.0001161240610824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,25822,1816,1.23 [1.19-1.26],4.2288207917358624e-44
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,25808,1814,1.25 [1.17-1.32],6.003315497157035e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF5,Fibroblast growth factor 5,25143,1785,1.28 [1.13-1.45],9.940282609536638e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,25671,1804,0.82 [0.72-0.92],0.0008775425741686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,25671,1804,1.84 [1.53-2.21],6.343154158433008e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,22256,1575,1.35 [1.26-1.45],1.577055454088206e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FIS1,Mitochondrial fission 1 protein,25585,1810,1.11 [1.05-1.17],0.0001044613862873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,25451,1778,1.21 [1.10-1.33],0.0001309762078586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,25451,1778,1.06 [1.02-1.11],0.0079724907019963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3,Receptor-type tyrosine-protein kinase FLT3,24989,1767,0.78 [0.68-0.89],0.0003242489084495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,25921,1826,1.28 [1.13-1.44],6.360777286476118e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,22173,1569,1.22 [1.10-1.35],0.0002186108877595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR1,Folate receptor alpha,25550,1793,1.36 [1.19-1.57],1.3613855777710857e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR2,Folate receptor beta,25866,1814,1.29 [1.12-1.48],0.0003523948827191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO1,Forkhead box protein O1,25598,1805,1.08 [1.03-1.13],0.0030555943143592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO3,Forkhead box protein O3,24989,1767,1.07 [1.02-1.12],0.0023892158648989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FST,Follistatin,25685,1817,1.21 [1.11-1.31],3.956111687561663e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,21631,1536,2.13 [1.73-2.62],8.256483830124381e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,25562,1808,2.08 [1.84-2.36],1.4799924429347794e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,22136,1568,1.10 [1.04-1.16],0.0003562453801041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,21736,1552,1.24 [1.15-1.33],1.5067155125884073e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FURIN,Furin,25671,1804,1.61 [1.43-1.81],8.4665972458209895e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUS,RNA-binding protein FUS,24945,1764,1.18 [1.07-1.30],0.0005807439540124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",21785,1551,0.92 [0.85-1.00],0.0387689382230057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,25866,1814,1.42 [1.30-1.55],5.063731074839912e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,21631,1536,1.12 [1.02-1.22],0.0135097511567313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAL,Galanin peptides,25724,1819,0.83 [0.78-0.89],1.1224087551722948e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,25512,1792,1.68 [1.46-1.93],5.15778860196215e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,25852,1817,0.71 [0.61-0.84],3.0458681842716777e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,22239,1578,1.34 [1.12-1.60],0.0010789176232073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,21276,1516,1.28 [1.07-1.53],0.0060850413254043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS6,Growth arrest-specific protein 6,25746,1812,1.62 [1.38-1.90],3.516756257536602e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,22173,1569,1.21 [1.17-1.25],1.488462453149147e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP1,Guanylate-binding protein 1,22137,1569,1.12 [1.04-1.20],0.003424684730153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCG,Pro-glucagon,24989,1767,1.06 [1.02-1.10],0.0006480728988653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,21211,1513,1.53 [1.43-1.63],1.5609510369731663e-39
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",25512,1792,1.14 [1.01-1.29],0.0320960490592451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,25930,1825,1.32 [1.22-1.44],2.2390227587270025e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,24989,1767,1.21 [1.13-1.28],4.5718279361043104e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,25822,1816,2.00 [1.73-2.31],3.3466739362229047e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA2,GDNF family receptor alpha-2,25512,1792,1.25 [1.02-1.53],0.0290313143755368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRAL,GDNF family receptor alpha-like,21533,1526,0.81 [0.75-0.88],3.8101936007772985e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGH,Gamma-glutamyl hydrolase,25131,1769,1.40 [1.25-1.57],1.2343464670807133e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,25559,1796,1.45 [1.35-1.56],8.150344518553634e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,25451,1778,1.60 [1.35-1.89],5.1155033168839e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRL,Appetite-regulating hormone,25613,1801,1.12 [1.06-1.18],2.486528706821094e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIP,Gastric inhibitory polypeptide,21631,1536,1.24 [1.12-1.38],4.240909075009297e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,22173,1569,1.54 [1.33-1.79],1.1377874249785752e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GKN1,Gastrokine-1,24538,1723,1.27 [1.08-1.49],0.0030987165557381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,21691,1547,1.56 [1.38-1.76],4.842162726167556e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLB1,Beta-galactosidase,25451,1778,1.23 [1.12-1.35],2.748825624771125e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,25161,1772,1.25 [1.16-1.34],1.5333234937042292e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX,Glutaredoxin-1,25461,1789,1.08 [1.00-1.15],0.0427547617167541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",21736,1552,1.08 [1.03-1.14],0.0033027157419578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,21711,1537,1.38 [1.26-1.52],1.0364875857467323e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,24989,1767,1.10 [1.03-1.17],0.0054462044936678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLM2,Protein GOLM2,25866,1814,1.72 [1.43-2.07],5.914539881777692e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,24831,1750,0.92 [0.87-0.98],0.0055230927029351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC5,Glypican-5,25451,1778,0.88 [0.82-0.95],0.000771416660891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,22130,1568,1.34 [1.24-1.46],2.658386177214233e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,25026,1760,1.26 [1.14-1.40],1.532316882441604e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR15L,Protein GPR15L,22149,1572,1.14 [1.06-1.23],0.0005406574473542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,25161,1772,1.27 [1.19-1.35],1.2859524575363454e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,22130,1568,1.30 [1.21-1.40],3.394977862859424e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRIK2,"Glutamate receptor ionotropic, kainate 2",22205,1573,0.82 [0.71-0.94],0.0049936189313609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRN,Progranulin,25479,1791,1.73 [1.47-2.04],7.044067901957875e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRP,Gastrin-releasing peptide,21631,1536,1.17 [1.07-1.28],0.0008975459906034
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",25512,1792,1.29 [1.21-1.37],4.138968600437216e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,22168,1563,0.45 [0.35-0.57],3.287715965451048e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA1,Glutathione S-transferase A1,25581,1797,1.08 [1.03-1.14],0.0011006124210515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCA2A,Guanylin,25483,1791,1.28 [1.13-1.44],7.761882523073874e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,25701,1811,1.21 [1.14-1.30],9.837402648507927e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GYS1,"Glycogen [starch] synthase, muscle",25161,1772,1.07 [1.02-1.12],0.0053826856118681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,25852,1817,1.07 [1.04-1.11],1.027069032043476e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,25820,1812,1.40 [1.31-1.49],3.5465819185875365e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,25606,1800,1.83 [1.63-2.05],1.3454519368858778e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HCLS1,Hematopoietic lineage cell-specific protein,25921,1826,1.11 [1.03-1.20],0.0057114039335569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDGFL2,Hepatoma-derived growth factor-related protein 2,22173,1569,1.08 [1.00-1.16],0.039489902084254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,21736,1552,1.96 [1.67-2.30],1.9884815040427911e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPH,Hephaestin,22239,1578,1.69 [1.41-2.03],2.1749589051039364e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEXIM1,Protein HEXIM1,25598,1805,1.07 [1.02-1.13],0.0088484233532538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,25921,1826,1.78 [1.60-1.97],5.1442348498318015e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,24989,1767,1.08 [1.02-1.14],0.004550872209655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HHEX,Hematopoietically-expressed homeobox protein HHEX,22173,1569,1.11 [1.04-1.18],0.0013240413770879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1,Huntingtin-interacting protein 1,21528,1521,0.85 [0.74-0.98],0.0272417509085129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,22138,1566,1.27 [1.17-1.38],4.122771352466728e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HJV,Hemojuvelin,22205,1573,1.23 [1.11-1.37],0.000146941210628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",22205,1573,1.20 [1.04-1.40],0.0157047830989839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",25598,1805,1.45 [1.25-1.68],9.881113468535055e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",21631,1536,1.15 [1.05-1.27],0.0032456587133785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX1,Heme oxygenase 1,25318,1781,1.10 [1.01-1.20],0.0214527540136542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX2,Heme oxygenase 2,25026,1760,1.13 [1.04-1.23],0.0028306437765129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNMT,Histamine N-methyltransferase,25325,1769,1.24 [1.14-1.36],6.114463015282734e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,22205,1573,1.10 [1.01-1.21],0.0380138277749218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,24989,1767,0.69 [0.61-0.77],6.056724604578308e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPSE,Heparanase,21958,1561,1.09 [1.04-1.15],0.0008523938508207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,21631,1536,0.87 [0.75-1.00],0.0488975282305476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,25512,1792,1.36 [1.22-1.52],5.2792297944016015e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,25598,1805,1.24 [1.12-1.37],1.6631961741913027e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,22173,1569,1.18 [1.09-1.28],3.03413265195772e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB6,Heat shock protein beta-6,25852,1817,1.18 [1.06-1.31],0.0018931925368603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,25396,1790,1.64 [1.40-1.92],7.622338639802008e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",25671,1804,1.13 [1.06-1.21],0.0002981401095769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,25449,1798,1.54 [1.32-1.80],3.705983642569108e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,25930,1825,1.60 [1.33-1.93],1.0689695884461238e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICA1,Islet cell autoantigen 1,25143,1785,1.06 [1.00-1.11],0.0388622865276513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,25492,1798,2.19 [1.95-2.47],7.755087041931267e-40
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM3,Intercellular adhesion molecule 3,25930,1825,1.26 [1.08-1.48],0.0042151274645517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,25613,1801,1.70 [1.55-1.86],1.0395382430277556e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDS,Iduronate 2-sulfatase,25921,1826,0.62 [0.41-0.94],0.0225676416929136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,25852,1817,1.39 [1.27-1.52],1.4208001212979546e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,21619,1533,1.98 [1.81-2.18],2.4033760017505142e-48
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNG,Interferon gamma,25143,1785,1.05 [1.01-1.09],0.0074210578560479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR1,Interferon gamma receptor 1,25724,1819,1.29 [1.05-1.58],0.0146960347194246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR2,Interferon gamma receptor 2,25451,1778,1.13 [1.05-1.22],0.0015437147348633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNLR1,Interferon lambda receptor 1,25598,1805,1.36 [1.22-1.51],3.272125313850393e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,22235,1580,0.67 [0.58-0.77],6.233562125750634e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,25606,1800,1.45 [1.22-1.73],2.625316277228069e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,25886,1823,1.08 [1.04-1.12],1.544099184032936e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,25880,1825,1.24 [1.16-1.32],4.2697503972400254e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,25691,1811,0.84 [0.73-0.97],0.0189535755962634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,25278,1777,2.00 [1.86-2.14],2.5008352634892678e-82
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,25930,1825,1.75 [1.54-1.98],1.1962675096928249e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,25613,1801,1.78 [1.58-1.99],6.801998213981689e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,22238,1586,1.44 [1.25-1.66],6.934358318464177e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLON5,IgLON family member 5,21457,1520,1.06 [1.01-1.11],0.0268127513450185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,25512,1792,1.32 [1.19-1.47],2.0923724773479145e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,25613,1801,1.78 [1.56-2.03],3.065173819490063e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,22239,1578,1.23 [1.17-1.30],2.205506340955737e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,25724,1819,1.87 [1.63-2.15],2.350522532660373e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12A_IL12B,Interleukin-12,25512,1792,0.89 [0.85-0.95],0.0001165950400184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12B,Interleukin-12 subunit beta,25921,1826,0.85 [0.79-0.91],7.545547962663699e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB2,Interleukin-12 receptor subunit beta-2,21601,1534,0.82 [0.72-0.93],0.0020668996056582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13,Interleukin-13,25143,1785,1.09 [1.01-1.17],0.0293165854341331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA1,Interleukin-13 receptor subunit alpha-1,25271,1776,1.47 [1.23-1.75],2.8445544236892944e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,25598,1805,1.86 [1.65-2.09],4.484962936288721e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,25143,1785,1.29 [1.14-1.45],3.593856937239496e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL16,Pro-interleukin-16,25921,1826,1.18 [1.08-1.28],9.264031157242836e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17C,Interleukin-17C,25143,1785,1.12 [1.06-1.19],0.0002034445958579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,25504,1809,1.31 [1.21-1.43],1.154081487375262e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,25691,1811,1.70 [1.49-1.94],5.0070394904568525e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18R1,Interleukin-18 receptor 1,25921,1826,1.33 [1.19-1.50],1.6356404708473344e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,24979,1758,1.20 [1.14-1.27],3.1431556928087136e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1B,Interleukin-1 beta,25018,1777,1.10 [1.03-1.17],0.002905182639603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R1,Interleukin-1 receptor type 1,25559,1796,1.49 [1.24-1.79],1.610874961994479e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R2,Interleukin-1 receptor type 2,25550,1809,1.36 [1.10-1.68],0.0038614205941114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,25837,1817,1.21 [1.10-1.32],5.785224070274347e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,25143,1785,0.83 [0.75-0.92],0.0003043106769049
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,25547,1807,1.30 [1.22-1.38],2.044338890334603e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,22130,1568,1.31 [1.22-1.40],9.731512185262856e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,25451,1792,1.67 [1.51-1.85],2.0744904967841532e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RB,Interleukin-2 receptor subunit beta,25143,1785,0.82 [0.73-0.93],0.0017486361687059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL32,Interleukin-32,25598,1805,1.10 [1.01-1.20],0.032681160630937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36A,Interleukin-36 alpha,21601,1534,1.10 [1.02-1.18],0.0114612378837112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,25598,1805,1.66 [1.49-1.84],7.333691714912725e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,25512,1792,1.30 [1.24-1.35],6.603174136413344e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,25613,1801,1.59 [1.26-2.00],9.709487036598203e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,25606,1800,0.76 [0.71-0.82],5.11645640397202e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,24990,1755,1.10 [1.02-1.19],0.0106634504923957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,22130,1568,1.43 [1.30-1.57],4.655291505260532e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,21736,1552,1.50 [1.37-1.64],1.2964419591467205e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBC,Inhibin beta C chain,25606,1800,1.27 [1.14-1.41],8.901523317584359e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",21631,1536,1.17 [1.08-1.26],7.990226068751226e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",25512,1792,1.05 [1.01-1.09],0.0272431176451602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL3,Insulin-like 3,22173,1569,0.86 [0.81-0.92],1.228949879362029e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL5,Insulin-like peptide INSL5,22149,1572,1.13 [1.08-1.18],4.78537239561898e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IPCEF1,Interactor protein for cytohesin exchange factors 1,25403,1773,1.10 [1.05-1.15],8.003357145723029e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IQGAP2,Ras GTPase-activating-like protein IQGAP2,25512,1792,1.08 [1.01-1.16],0.0323645844443572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK1,Interleukin-1 receptor-associated kinase 1,25143,1785,1.09 [1.03-1.15],0.0048669267878037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,24640,1728,1.19 [1.07-1.32],0.0012074918481958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM1,Isthmin-1,25598,1805,1.34 [1.21-1.49],5.87850884002144e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA11,Integrin alpha-11,25598,1805,0.76 [0.67-0.86],7.958547437499163e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA2,Integrin alpha-2,21736,1552,0.82 [0.70-0.94],0.0062142234975392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA5,Integrin alpha-5,25606,1800,1.58 [1.34-1.86],3.693842322176114e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAM,Integrin alpha-M,25606,1800,0.71 [0.62-0.81],5.125997460320757e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAV,Integrin alpha-V,25852,1817,0.58 [0.46-0.74],9.638327756452351e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAX,Integrin alpha-X,21824,1552,1.14 [1.04-1.25],0.0044327429843885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB2,Integrin beta-2,25448,1791,0.79 [0.68-0.92],0.0019057746505457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB7,Integrin beta-7,25852,1817,1.10 [1.00-1.20],0.0405016999360039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGBL1,Integrin beta-like protein 1,22235,1580,1.41 [1.25-1.60],4.2584471079281126e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,25691,1811,1.35 [1.22-1.51],2.8959447902853707e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,22268,1588,1.21 [1.03-1.42],0.0192760286087083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPA,Inosine triphosphate pyrophosphatase,21528,1521,1.09 [1.01-1.17],0.0257388491287601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",21631,1536,1.09 [1.02-1.16],0.0143547663432249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM2,Junctional adhesion molecule B,25866,1814,1.25 [1.07-1.47],0.0047955037823659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM3,Junctional adhesion molecule C,21736,1552,1.13 [1.03-1.24],0.0088580878765351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JCHAIN,Immunoglobulin J chain,25143,1785,1.13 [1.06-1.21],0.00039073440152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,25512,1792,0.81 [0.74-0.88],2.889974764829724e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCTD5,BTB/POZ domain-containing protein KCTD5,21745,1540,1.17 [1.06-1.29],0.0018105236202078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHK,Ketohexokinase,21631,1536,1.16 [1.07-1.25],0.0002188688545615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA2013,Uncharacterized protein KIAA2013,22130,1568,0.90 [0.81-1.00],0.0482188624912333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,24989,1767,1.09 [1.03-1.16],0.0023180197626528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,25613,1801,0.65 [0.59-0.72],1.2550771129942962e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLF4,Krueppel-like factor 4,21521,1528,1.28 [1.15-1.44],1.2843312780334816e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,25590,1798,1.43 [1.30-1.58],1.6392889662864374e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,25427,1788,1.35 [1.18-1.56],2.589247066512178e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK13,Kallikrein-13,25044,1752,1.43 [1.31-1.56],4.715023732166814e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK14,Kallikrein-14,25852,1817,1.18 [1.08-1.29],0.0001324368315865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,25852,1817,1.13 [1.06-1.21],0.0001949048371675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK6,Kallikrein-6,25637,1803,0.83 [0.73-0.94],0.0031595489087815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK8,Kallikrein-8,24739,1744,1.28 [1.14-1.44],2.342633118258552e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",25512,1792,1.17 [1.12-1.22],2.8632613415656725e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",25565,1803,1.21 [1.14-1.28],8.281862697096376e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",21521,1528,1.11 [1.04-1.18],0.0021542239953329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYNU,Kynureninase,25921,1826,1.27 [1.17-1.38],3.838737870259316e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L1CAM,Neural cell adhesion molecule L1,25671,1804,1.25 [1.08-1.43],0.0019855613399353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,25512,1792,0.90 [0.81-1.00],0.047232006012749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,25593,1813,1.38 [1.26-1.51],1.1744300586542377e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,25451,1778,1.05 [1.01-1.10],0.0245023728732809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA4,Laminin subunit alpha-4,25724,1819,1.45 [1.29-1.62],1.6900172011255164e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMB1,Laminin subunit beta-1,21631,1536,1.27 [1.08-1.49],0.0033662249310697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,21620,1536,1.22 [1.06-1.41],0.0057590717783468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP2,Lysosome-associated membrane glycoprotein 2,24836,1742,1.59 [1.28-1.99],4.155695032921197e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,25873,1818,1.58 [1.48-1.68],1.8011706819396868e-41
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT2,Linker for activation of T-cells family member 2,25512,1792,1.05 [1.01-1.08],0.0074129724834768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,25405,1777,1.55 [1.37-1.74],8.23476870467886e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBP,Lipopolysaccharide-binding protein,25691,1811,1.10 [1.03-1.18],0.0032604001895749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBR,Delta(14)-sterol reductase LBR,25866,1814,1.10 [1.05-1.16],0.0002624347675352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN15,Lipocalin-15,22205,1573,1.10 [1.02-1.18],0.0119608155466697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,24805,1751,1.37 [1.25-1.50],5.283828661691015e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCP1,Plastin-2,22235,1580,1.11 [1.01-1.22],0.0297348263205711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLR,Low-density lipoprotein receptor,25682,1802,1.11 [1.03-1.20],0.0067060058768003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,22239,1578,1.19 [1.11-1.28],1.2466764994813238e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEG1,Protein LEG1 homolog,20971,1500,1.16 [1.09-1.24],1.1831048320468434e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEO1,RNA polymerase-associated protein LEO1,22205,1573,1.22 [1.05-1.41],0.0093833589538359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,22205,1573,1.27 [1.17-1.38],3.055960552035473e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS1,Galectin-1,25613,1801,1.35 [1.21-1.52],2.5525957330008457e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3,Galectin-3,25681,1806,1.46 [1.28-1.67],1.3282277848238558e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,22268,1588,1.37 [1.20-1.55],1.3227618123676602e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,25593,1813,1.45 [1.36-1.56],9.701728537114806e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS7_LGALS7B,Galectin-7,25569,1801,1.20 [1.09-1.32],0.0002523726614915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS8,Galectin-8,25866,1814,1.11 [1.04-1.18],0.0019793849172852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,25594,1810,1.77 [1.57-1.99],1.959508118221945e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,25724,1819,1.55 [1.40-1.73],3.725068685268583e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIF,Leukemia inhibitory factor,25026,1760,1.20 [1.12-1.29],6.209492627078748e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,25581,1799,1.59 [1.40-1.80],1.2773737523172301e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,25930,1825,1.33 [1.14-1.54],0.0001942003762366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,25787,1817,1.31 [1.16-1.48],8.716348471613055e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,25143,1785,1.41 [1.28-1.55],4.861704647028742e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIPF,Gastric triacylglycerol lipase,21631,1536,1.23 [1.13-1.33],4.912712065772624e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB2,Lamin-B2,22173,1569,1.58 [1.35-1.84],4.538237518246445e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD1,Leiomodin-1,22205,1573,1.31 [1.16-1.49],1.6498877971803315e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD2,Leiomodin-2,21521,1528,0.91 [0.83-0.99],0.0360143087563949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",21631,1536,1.09 [1.03-1.15],0.0018847451799783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,25512,1792,1.08 [1.00-1.16],0.0453982494344485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,21528,1521,1.09 [1.02-1.17],0.0073966646851712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,22268,1588,1.75 [1.47-2.08],3.337156196586355e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,25790,1811,1.18 [1.05-1.33],0.0052001538262105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP1,Prolow-density lipoprotein receptor-related protein 1,25512,1792,1.23 [1.06-1.42],0.0078290577564343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,25613,1801,1.35 [1.20-1.51],5.674082115545568e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,25866,1814,1.14 [1.06-1.21],0.0001593535404525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,25512,1792,1.44 [1.31-1.60],6.398833147614775e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,25143,1785,0.64 [0.58-0.71],8.770821867510176e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,22205,1573,0.62 [0.51-0.76],1.4676467449109912e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSM1,U6 snRNA-associated Sm-like protein LSm1,24989,1767,1.08 [1.01-1.15],0.0250864493330857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSP1,Lymphocyte-specific protein 1,25598,1805,1.14 [1.03-1.25],0.0095830632867079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,25852,1817,1.26 [1.19-1.33],1.7583067773084398e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,25930,1825,1.46 [1.27-1.67],7.57272774124277e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,24989,1767,1.26 [1.17-1.35],2.552865798145518e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,25454,1804,1.63 [1.41-1.88],2.002989540665076e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LXN,Latexin,25320,1770,0.91 [0.85-0.97],0.0049148834093424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY6D,Lymphocyte antigen 6D,25456,1800,1.15 [1.03-1.29],0.0129801822257534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,25451,1778,1.33 [1.19-1.49],9.60526158619834e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD3,Ly6/PLAUR domain-containing protein 3,25478,1787,1.15 [1.02-1.30],0.0227942014319778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,24989,1767,1.13 [1.04-1.23],0.0044316921271879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,25367,1773,1.14 [1.07-1.22],7.156412172407213e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC4,Apical endosomal glycoprotein,22130,1568,1.23 [1.14-1.33],9.692248898687497e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",21631,1536,1.49 [1.24-1.78],2.186067608070027e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN2B2,Epididymis-specific alpha-mannosidase,22239,1578,1.18 [1.08-1.28],9.61355203949582e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC1,MANSC domain-containing protein 1,25671,1804,1.40 [1.21-1.62],5.489009434620277e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC4,MANSC domain-containing protein 4,21528,1521,1.10 [1.02-1.18],0.0086475157344335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2,Microtubule-associated protein 2,22173,1569,1.11 [1.01-1.23],0.0393268173058797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK9,Mitogen-activated protein kinase 9,25598,1805,1.13 [1.03-1.24],0.009307076763242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPRE3,Microtubule-associated protein RP/EB family member 3,21457,1520,0.94 [0.89-0.99],0.0106352489677386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARCO,Macrophage receptor MARCO,25613,1801,1.37 [1.17-1.60],8.13268603899416e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MASP1,Mannan-binding lectin serine protease 1,25405,1777,1.23 [1.02-1.48],0.0335918902364335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,25638,1816,1.58 [1.37-1.81],7.165723782725731e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN3,Matrilin-3,25403,1773,1.38 [1.21-1.56],9.64194759572524e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAVS,Mitochondrial antiviral-signaling protein,24989,1767,1.08 [1.03-1.13],0.0017213858551521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MBL2,Mannose-binding protein C,21952,1568,1.06 [1.02-1.11],0.0079074463868362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCAM,Cell surface glycoprotein MUC18,25691,1811,0.80 [0.70-0.90],0.000384109456339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEMP1,Mast cell-expressed membrane protein 1,21601,1534,1.09 [1.03-1.15],0.0011353172706829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,25503,1791,1.19 [1.08-1.30],0.0002161092855625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,25451,1778,0.93 [0.88-0.99],0.019925544472223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,25587,1799,1.33 [1.23-1.43],5.75624572099945e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",21631,1536,1.07 [1.01-1.13],0.0145863770093276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF9,Multiple epidermal growth factor-like domains protein 9,25837,1817,1.54 [1.27-1.87],1.5213478904541149e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1A,Meprin A subunit alpha,22149,1572,1.16 [1.09-1.24],4.930035620646678e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,25613,1801,0.92 [0.89-0.95],4.484019704153206e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,25593,1813,0.76 [0.65-0.90],0.0012074207147036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MERTK,Tyrosine-protein kinase Mer,25921,1826,1.24 [1.06-1.46],0.0085340504233593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MET,Hepatocyte growth factor receptor,25687,1806,0.63 [0.51-0.78],3.0080448754672467e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",25598,1805,1.08 [1.03-1.14],0.0016145966588885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP2,Methionine aminopeptidase 2,25822,1816,1.10 [1.02-1.18],0.0098560314524226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,21736,1552,0.80 [0.69-0.93],0.0044450761814415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFGE8,Lactadherin,25606,1800,1.38 [1.26-1.51],1.3484267003511608e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MIA,Melanoma-derived growth regulatory protein,25671,1804,0.85 [0.77-0.95],0.0034621639103663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLN,Promotilin,25598,1805,1.10 [1.05-1.15],9.38983201746744e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,25512,1792,1.22 [1.16-1.28],1.1101823209004981e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP1,Interstitial collagenase,24715,1750,1.13 [1.08-1.19],9.94786404559225e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,25568,1814,1.19 [1.12-1.27],5.248723831975939e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,25666,1803,1.68 [1.56-1.80],2.988373867513882e-49
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP3,Stromelysin-1,25606,1800,1.14 [1.04-1.24],0.0031278303111947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,25124,1769,1.44 [1.32-1.58],3.306815503431921e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,25827,1813,1.21 [1.16-1.27],1.1738446944808432e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,25572,1800,1.28 [1.20-1.37],5.6781211895277934e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOCS2,Molybdopterin synthase catalytic subunit,21736,1552,1.12 [1.04-1.20],0.0014284163528661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,25852,1817,0.87 [0.77-0.98],0.0276433103717761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORF4L2,Mortality factor 4-like protein 2,21457,1520,0.81 [0.70-0.95],0.0080575529536032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPI,Mannose-6-phosphate isomerase,25512,1792,1.05 [1.00-1.10],0.0384981693808537
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPO,Myeloperoxidase,25606,1800,1.11 [1.03-1.21],0.0090052894020919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,22256,1575,1.79 [1.52-2.11],2.136797077897881e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,25475,1791,1.34 [1.27-1.42],1.5113882644046203e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSMB,Beta-microseminoprotein,25539,1799,1.31 [1.23-1.39],3.033681049330907e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,25866,1814,1.42 [1.30-1.55],1.6784996847245274e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MST1,Hepatocyte growth factor-like protein,21939,1552,1.10 [1.02-1.19],0.0194264763689263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,25161,1772,0.77 [0.71-0.83],4.5840276863253046e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,21824,1552,1.05 [1.01-1.10],0.0177165184586297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS2,Protein MTSS 2,22130,1568,1.07 [1.02-1.12],0.0051048973268676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,21824,1552,1.21 [1.12-1.30],2.606326056661916e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC13,Mucin-13,25026,1760,1.17 [1.08-1.27],0.0001291118282636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,25143,1785,1.23 [1.17-1.29],3.173189309441936e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,21736,1552,0.76 [0.64-0.89],0.0007168013868194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL6B,Myosin light chain 6B,21624,1545,0.90 [0.84-0.96],0.0008896097478863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,25677,1818,1.44 [1.34-1.55],2.8478399509139797e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,21736,1552,1.32 [1.06-1.63],0.0118462129881657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAPRT,Nicotinate phosphoribosyltransferase,22173,1569,0.73 [0.62-0.86],0.000189358872746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,25671,1804,1.45 [1.24-1.70],3.421663271080656e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBN,Nibrin,25143,1785,1.08 [1.01-1.15],0.0173598645536413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM1,Neural cell adhesion molecule 1,25691,1811,0.74 [0.65-0.84],8.701293666391147e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM2,Neural cell adhesion molecule 2,25606,1800,0.76 [0.64-0.89],0.0006041786595988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,25866,1814,0.64 [0.57-0.71],3.82940655082416e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCF2,Neutrophil cytosol factor 2,25551,1804,1.05 [1.00-1.09],0.0416926385175218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,22149,1572,1.18 [1.02-1.36],0.0244822655451203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCS1,Neuronal calcium sensor 1,25852,1817,1.21 [1.04-1.41],0.0124092491261187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,22130,1568,1.08 [1.01-1.16],0.0198732948429043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,25581,1799,1.76 [1.55-2.00],1.5012971621783138e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN4,Nectin-4,25671,1804,1.41 [1.24-1.60],1.737835336787087e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,24948,1758,1.35 [1.24-1.47],4.22764791107272e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,25671,1804,0.88 [0.80-0.96],0.0065211530939006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL2,Protein kinase C-binding protein NELL2,25724,1819,0.82 [0.71-0.95],0.0075389748223467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NENF,Neudesin,22130,1568,0.92 [0.87-0.98],0.0054065394195328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,25921,1826,1.35 [1.17-1.55],3.196764853354935e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",25143,1785,1.13 [1.05-1.20],0.0003875858064188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKBIE,NF-kappa-B inhibitor epsilon,24989,1767,1.15 [1.06-1.25],0.000921325954253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGRN,Neugrin,22173,1569,1.28 [1.01-1.63],0.0425993580445825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,21243,1514,2.08 [1.78-2.44],1.5034558054027388e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID1,Nidogen-1,25614,1807,1.28 [1.16-1.42],2.1379397982003217e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID2,Nidogen-2,25606,1800,1.08 [1.02-1.14],0.0067016424189956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME3,Nucleoside diphosphate kinase 3,25638,1816,1.28 [1.07-1.52],0.0055176457142767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOMO1,Nodal modulator 1,25606,1800,1.58 [1.33-1.88],2.6504718704846306e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",25026,1760,1.11 [1.02-1.21],0.0111477791928505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,25930,1825,0.70 [0.54-0.90],0.0065811453456287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,25930,1825,0.86 [0.76-0.96],0.009125742967142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,21872,1552,2.18 [2.01-2.38],3.2033847194262954e-73
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,25613,1801,1.59 [1.40-1.80],3.19304219351858e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPL,N-acetylneuraminate lyase,22239,1578,1.29 [1.17-1.43],6.79509064703724e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,25161,1772,1.09 [1.05-1.13],7.082708315538443e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,25606,1800,1.37 [1.25-1.50],1.0504689372269938e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTXR,Neuronal pentraxin receptor,25613,1801,0.76 [0.68-0.86],8.632805009747669e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPY,Pro-neuropeptide Y,25852,1817,1.07 [1.01-1.14],0.0290253364228018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRCAM,Neuronal cell adhesion molecule,25613,1801,0.73 [0.63-0.84],2.0707794878550788e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,22173,1569,1.59 [1.39-1.83],1.9183492692481198e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5E,5'-nucleotidase,25671,1804,1.17 [1.09-1.26],4.072884364057978e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF3,Neurotrophin-3,25598,1805,1.18 [1.06-1.32],0.0033243118666046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,25613,1801,0.78 [0.66-0.92],0.0025531561790109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK3,NT-3 growth factor receptor,25866,1814,0.54 [0.44-0.65],7.209066991745317e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,25613,1801,1.14 [1.10-1.20],1.0417209855063947e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUCB2,Nucleobindin-2,25819,1814,1.26 [1.13-1.40],2.4040683580932595e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDC,Nuclear migration protein nudC,25921,1826,1.09 [1.02-1.16],0.0136505506913969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT16,U8 snoRNA-decapping enzyme,22113,1570,1.06 [1.00-1.11],0.0358108778375039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,25606,1800,1.14 [1.05-1.23],0.0019813870275773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OBP2B,Odorant-binding protein 2b,25359,1771,0.89 [0.83-0.95],0.0007027571375996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,22205,1573,1.94 [1.76-2.14],3.9067954996789236e-40
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ODAM,Odontogenic ameloblast-associated protein,24982,1755,0.85 [0.78-0.92],9.45587869356913e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGN,Mimecan,25606,1800,1.22 [1.10-1.35],0.0001748470855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLFM4,Olfactomedin-4,20934,1486,1.07 [1.03-1.11],0.0010280238807406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,25367,1786,1.19 [1.13-1.26],4.339170455313611e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMD,Osteomodulin,25724,1819,0.74 [0.67-0.81],1.5304183502667434e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,25512,1792,0.76 [0.72-0.81],3.2955680039288095e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,22187,1583,2.58 [2.06-3.23],2.053155627657336e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,25638,1816,1.77 [1.57-2.00],2.481420120233304e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,25467,1797,1.28 [1.22-1.35],2.7692799678276726e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,25738,1812,2.03 [1.67-2.47],1.4052676129906528e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTUD7B,OTU domain-containing protein 7B,22205,1573,1.08 [1.01-1.17],0.027820907865372
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",21631,1536,1.11 [1.04-1.19],0.0021377403798488
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXT,Oxytocin-neurophysin 1,25866,1814,1.07 [1.04-1.10],2.755896163402101e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",P4HB,Protein disulfide-isomerase,25468,1792,1.26 [1.13-1.40],1.5081831283995514e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,22205,1573,0.90 [0.85-0.96],0.000834564934323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,25161,1772,1.18 [1.10-1.26],1.2429194415728131e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM,Paralemmin-1,22030,1562,1.19 [1.01-1.40],0.043139822700588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,22173,1569,1.71 [1.53-1.90],1.7469664038989554e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,25800,1823,1.31 [1.13-1.52],0.0003892680239909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAMR1,Inactive serine protease PAMR1,25606,1800,1.16 [1.00-1.35],0.0473276414405073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARP1,Poly [ADP-ribose] polymerase 1,25598,1805,1.12 [1.05-1.19],0.0002293858588884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAXX,Protein PAXX,21736,1552,1.15 [1.04-1.27],0.0046373001124079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,21688,1550,1.22 [1.12-1.34],1.5092634006763909e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH17,Protocadherin-17,25613,1801,0.76 [0.68-0.86],5.983112000502279e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH9,Protocadherin-9,22149,1572,0.79 [0.70-0.90],0.0003742376795173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDHB15,Protocadherin beta-15,22130,1568,0.86 [0.76-0.98],0.0237687798592486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,25930,1825,1.32 [1.19-1.46],1.0456705159532877e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD5,Programmed cell death protein 5,25866,1814,1.13 [1.05-1.21],0.0007826649466214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD6,Programmed cell death protein 6,25613,1801,1.07 [1.01-1.14],0.0322702955147344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFA,Platelet-derived growth factor subunit A,25930,1825,1.11 [1.05-1.18],0.0003258028379257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFB,Platelet-derived growth factor subunit B,25724,1819,1.11 [1.06-1.16],3.581466212359103e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFC,Platelet-derived growth factor C,24989,1767,1.18 [1.02-1.37],0.0291824849704032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,25613,1801,1.28 [1.11-1.47],0.0005374558509707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA3,Protein disulfide-isomerase A3,21736,1552,1.20 [1.01-1.44],0.0429336857030275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZD2,PDZ domain-containing protein 2,21528,1521,1.10 [1.01-1.18],0.0207949544205062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,21601,1534,1.32 [1.20-1.46],3.118508122910211e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PENK,Proenkephalin-A,21736,1552,1.32 [1.12-1.56],0.0009589830556823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PF4,Platelet factor 4,22100,1579,1.07 [1.02-1.13],0.0056820643618182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,22256,1575,1.34 [1.25-1.44],6.030483321363865e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,25921,1826,1.66 [1.41-1.95],1.1325860686242375e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,25787,1817,1.32 [1.21-1.44],3.967754687801216e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,21980,1572,1.39 [1.18-1.63],8.716862396850985e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,22149,1572,1.15 [1.05-1.25],0.0027274897346158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,25451,1778,1.27 [1.09-1.48],0.0024286178101756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,21736,1552,1.13 [1.02-1.26],0.0251997141014079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,25247,1777,1.32 [1.22-1.41],6.327824827276014e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,25284,1787,2.16 [1.97-2.36],5.205612942020277e-63
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,25598,1805,1.10 [1.03-1.18],0.003052686374128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,25606,1800,1.68 [1.45-1.94],1.4525226550899156e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,25606,1800,1.50 [1.35-1.66],1.802810784855829e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,25613,1801,1.29 [1.19-1.39],2.523282252397584e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD2,Polycystin-2,21528,1521,1.10 [1.02-1.19],0.0175991879756895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,25671,1804,2.26 [1.98-2.58],4.8819643664774835e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,25879,1821,0.85 [0.77-0.94],0.0013664811858779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",25551,1792,1.21 [1.13-1.30],2.091779977210937e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,25837,1817,1.35 [1.25-1.47],8.564959937217432e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAU,Urokinase-type plasminogen activator,25606,1800,1.27 [1.10-1.47],0.001047399013637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,25424,1806,2.38 [2.11-2.69],3.3691007208104774e-45
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLB1,"Phospholipase B1, membrane-associated",22173,1569,0.90 [0.83-0.97],0.0100120885972464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLEKHO1,Pleckstrin homology domain-containing family O member 1,22173,1569,1.09 [1.02-1.17],0.0097144157944135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLG,Plasminogen,21695,1552,1.59 [1.27-2.00],6.037944658541866e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN3,Perilipin-3,25613,1801,1.14 [1.04-1.24],0.0052923134541324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLTP,Phospholipid transfer protein,25834,1824,0.81 [0.73-0.90],6.989814041957865e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC1,Plexin domain-containing protein 1,24989,1767,0.75 [0.65-0.87],0.0002081768073029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB2,Plexin-B2,25808,1813,1.45 [1.23-1.72],1.1716817241396209e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,25507,1792,0.98 [0.96-1.00],0.0410982128514649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIPRP1,Inactive pancreatic lipase-related protein 1,22173,1569,1.07 [1.01-1.14],0.01492451106062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POF1B,Protein POF1B,21601,1534,1.16 [1.05-1.29],0.0052768472706055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",25512,1792,1.27 [1.16-1.39],1.205018308288465e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,22256,1575,0.63 [0.54-0.73],2.643946922084449e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,25161,1772,1.49 [1.32-1.68],7.10046589292953e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON3,Serum paraoxonase/lactonase 3,25724,1819,0.81 [0.73-0.89],3.0148822163378814e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POSTN,Periostin,22235,1580,0.77 [0.67-0.87],3.5935391151210855e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPBP,Platelet basic protein,22089,1581,1.09 [1.03-1.15],0.0048205607529321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPCDC,Phosphopantothenoylcysteine decarboxylase,25866,1814,1.09 [1.00-1.19],0.0409264996729798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPL,Periplakin,21601,1534,1.34 [1.15-1.56],0.0001487918155718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,22205,1573,1.28 [1.14-1.44],1.9723717596330296e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPY,Pancreatic prohormone,25545,1790,1.07 [1.03-1.11],0.001050470950661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PQBP1,Polyglutamine-binding protein 1,24989,1767,1.08 [1.01-1.15],0.0257687527597297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAME,Melanoma antigen preferentially expressed in tumors,21457,1520,0.79 [0.64-0.96],0.0181180043510058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,22235,1580,1.74 [1.54-1.97],1.2508045843117385e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,25743,1815,1.55 [1.36-1.76],1.9667275953126883e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",25143,1785,1.10 [1.04-1.16],0.0016439495653855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX6,Peroxiredoxin-6,25852,1817,0.89 [0.83-0.95],0.0003918434658538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PREB,Prolactin regulatory element-binding protein,25143,1785,1.21 [1.06-1.39],0.0039691777776897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG2,Bone marrow proteoglycan,22235,1580,1.18 [1.07-1.29],0.0005622024857901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,21624,1545,0.84 [0.70-1.00],0.0459633922958031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,24989,1767,1.10 [1.03-1.17],0.0032177663526198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRND,Prion-like protein doppel,22173,1569,1.16 [1.06-1.26],0.0012036091067708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROS1,Vitamin K-dependent protein S,22268,1588,1.31 [1.07-1.61],0.0090014651611102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,21631,1536,1.15 [1.00-1.31],0.0442718739706602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS2,Trypsin-2,25691,1811,1.31 [1.23-1.40],6.964188770164543e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS22,Brain-specific serine protease 4,21601,1534,1.23 [1.09-1.40],0.0013212430810161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS27,Serine protease 27,25520,1793,1.18 [1.07-1.31],0.0009140350724964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,25512,1807,2.17 [1.99-2.37],5.5099990210624575e-68
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTN3,Myeloblastin,24962,1756,1.17 [1.08-1.26],4.5046101228701584e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRUNE2,Protein prune homolog 2,21824,1552,1.24 [1.05-1.46],0.0114136257822491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,22041,1564,1.89 [1.68-2.13],2.397922775458758e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,25451,1778,1.08 [1.04-1.13],0.0001356407602673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSIP1,PC4 and SFRS1-interacting protein,25598,1805,1.08 [1.02-1.15],0.0054392255779323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMA1,Proteasome subunit alpha type-1,24989,1767,0.89 [0.81-0.99],0.0259807318981806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMC3,26S proteasome regulatory subunit 6A,21457,1520,0.70 [0.59-0.84],8.085735859532354e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSME1,Proteasome activator complex subunit 1,25422,1777,1.13 [1.01-1.27],0.0281740056439554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSRC1,Proline/serine-rich coiled-coil protein 1,24989,1767,1.12 [1.05-1.20],0.0010516623222347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,25408,1787,1.27 [1.10-1.46],0.000991247384674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,25026,1760,1.14 [1.01-1.27],0.0276608283694985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,25161,1772,1.19 [1.10-1.30],2.689436676804217e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,25451,1778,1.06 [1.00-1.12],0.0323160197601357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,22239,1578,1.68 [1.46-1.94],6.466642475322551e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,22149,1572,0.77 [0.69-0.85],1.6358187240296168e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,25356,1774,1.14 [1.00-1.30],0.0499051060469322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,22173,1569,0.82 [0.72-0.94],0.0031845997694521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,24919,1748,1.08 [1.00-1.16],0.0397384882632351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTX3,Pentraxin-related protein PTX3,25598,1805,1.19 [1.09-1.30],0.0001001114225597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,25866,1814,1.49 [1.36-1.64],8.63877996442081e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYY,Peptide YY,21528,1521,1.17 [1.12-1.23],1.2704722789766612e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,25608,1803,1.39 [1.20-1.63],2.007635020244073e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QSOX1,Sulfhydryl oxidase 1,21813,1552,1.18 [1.07-1.29],0.0004801346754858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6A,Ras-related protein Rab-6A,25598,1805,0.89 [0.81-0.97],0.0088735101036752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6B,Ras-related protein Rab-6B,25026,1760,1.10 [1.00-1.21],0.047972746035243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAP1A,Ras-related protein Rap-1A,21601,1534,0.91 [0.83-0.99],0.0263466804010748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,24989,1767,1.14 [1.01-1.28],0.0387421841953752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,25738,1812,1.42 [1.32-1.53],1.1515623766529629e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASSF2,Ras association domain-containing protein 2,24989,1767,1.10 [1.04-1.16],0.0008980787862374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,22205,1573,1.48 [1.34-1.64],4.3972303705266485e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,25512,1792,1.15 [1.10-1.21],2.133508894052244e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,25512,1792,1.27 [1.18-1.35],5.506574161415043e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP7,Retinoid-binding protein 7,22149,1572,1.08 [1.02-1.16],0.0131238368269723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCC1,Regulator of chromosome condensation,22130,1568,1.11 [1.02-1.21],0.0163012804605551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,25464,1797,1.42 [1.31-1.53],6.966291891640017e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,25930,1825,1.32 [1.23-1.41],4.321163222563109e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,25930,1825,1.23 [1.15-1.31],1.4043189205547715e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,25638,1816,1.49 [1.38-1.62],9.886205972006128e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,25606,1800,1.80 [1.57-2.07],1.862794878337869e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,25613,1801,1.24 [1.18-1.32],3.6817302310717e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,25512,1792,0.84 [0.75-0.94],0.0017395522939906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RETN,Resistin,25546,1802,1.20 [1.09-1.31],9.460105343209092e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMA,Repulsive guidance molecule A,25866,1814,0.73 [0.64-0.83],2.9143022610097377e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,21736,1552,1.20 [1.09-1.31],0.0001182578052639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,21528,1521,1.07 [1.00-1.15],0.0440408576656519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,22256,1575,1.69 [1.38-2.06],2.432053619254297e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE4,Ribonuclease 4,21557,1533,1.50 [1.27-1.77],1.929219533708316e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,22101,1566,1.78 [1.53-2.06],3.352634902936833e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,25790,1817,1.54 [1.33-1.78],6.027217005615363e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,21631,1536,2.08 [1.78-2.41],2.7529979693591517e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF31,E3 ubiquitin-protein ligase RNF31,21601,1534,0.80 [0.69-0.94],0.0051090453478502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF43,E3 ubiquitin-protein ligase RNF43,21824,1552,1.10 [1.03-1.18],0.0065261003203549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPL14,60S ribosomal protein L14,21631,1536,1.16 [1.05-1.29],0.0040647019612875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,24989,1767,1.32 [1.23-1.42],3.201004618065076e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,25451,1778,1.52 [1.35-1.70],1.7771533112392209e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO3,R-spondin-3,25852,1817,1.39 [1.20-1.61],1.2967943480416926e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RUVBL1,RuvB-like 1,24989,1767,1.05 [1.01-1.10],0.0084092043963895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A11,Protein S100-A11,25410,1786,1.10 [1.03-1.18],0.0062655404932379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A12,Protein S100-A12,25270,1785,1.07 [1.01-1.13],0.0135807125048501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A13,Protein S100-A13,21601,1534,1.19 [1.04-1.37],0.0123127302437157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100G,Protein S100-G,22205,1573,1.16 [1.05-1.27],0.0021531606371725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAMD9L,Sterile alpha motif domain-containing protein 9-like,25598,1805,1.07 [1.01-1.13],0.0174596954710295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SARG,Specifically androgen-regulated gene protein,22166,1577,1.05 [1.00-1.10],0.0298393731279188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SART1,U4/U6.U5 tri-snRNP-associated protein 1,21528,1521,1.13 [1.02-1.26],0.0241046303461233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCAMP3,Secretory carrier-associated membrane protein 3,25512,1792,1.06 [1.00-1.11],0.0319944173264653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARA5,Scavenger receptor class A member 5,25866,1814,1.28 [1.11-1.47],0.0005948827341731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB1,Scavenger receptor class B member 1,25026,1760,1.09 [1.01-1.18],0.0184273633405757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,24955,1737,1.70 [1.49-1.93],1.3818900053510652e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF1,Scavenger receptor class F member 1,25930,1825,1.20 [1.09-1.32],0.000114551334129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF2,Scavenger receptor class F member 2,25866,1814,1.19 [1.03-1.38],0.022122306047686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG2,Secretogranin-2,25757,1808,1.20 [1.06-1.37],0.0051428517626533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,25654,1817,0.69 [0.66-0.73],6.443200213987162e-41
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,21736,1552,1.88 [1.58-2.24],7.153979055987745e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,25685,1817,1.26 [1.21-1.31],5.282347978080692e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,25790,1811,1.29 [1.19-1.39],3.0417143073806985e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN4B,Sodium channel subunit beta-4,21631,1536,1.31 [1.17-1.46],3.636461766079483e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,21554,1530,1.27 [1.16-1.39],2.331264120215781e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRG1,Scrapie-responsive protein 1,22239,1578,1.33 [1.13-1.57],0.000737118792384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRIB,Protein scribble homolog,21631,1536,1.07 [1.02-1.13],0.0066986395905005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC1,Syndecan-1,25613,1801,1.12 [1.01-1.25],0.0324567454021304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDHB,Succinate dehydrogenase,22149,1572,1.09 [1.02-1.17],0.0070562563412695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEL1L,Protein sel-1 homolog 1,21631,1536,1.33 [1.15-1.55],0.0001387577026365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELE,E-selectin,25930,1825,1.41 [1.29-1.53],1.6268327845062038e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,22268,1588,0.51 [0.41-0.63],1.1079887274931327e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELL,L-selectin,22268,1588,0.63 [0.51-0.78],1.550059576702249e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELP,P-selectin,25691,1811,1.14 [1.06-1.22],0.0004424221316243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELPLG,P-selectin glycoprotein ligand 1,25598,1805,1.20 [1.06-1.37],0.0056217049445086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA3F,Semaphorin-3F,25613,1801,1.40 [1.19-1.64],4.379831600772442e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN3,Neuronal-specific septin-3,22205,1573,1.11 [1.04-1.18],0.0008999879289302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,22125,1564,1.55 [1.37-1.76],1.0388014987396448e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA1,Alpha-1-antitrypsin,21868,1554,2.51 [1.63-3.85],2.69370971832096e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA11,Serpin A11,25930,1825,1.19 [1.08-1.32],0.0005236414898666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,22203,1586,2.42 [1.88-3.11],6.722503077577565e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA9,Serpin A9,25392,1780,1.08 [1.03-1.14],0.0034311312613113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB8,Serpin B8,25921,1826,1.13 [1.07-1.20],5.576343889879913e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPIND1,Heparin cofactor 2,22222,1587,1.83 [1.55-2.16],1.2914103898056117e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,25930,1825,1.20 [1.13-1.28],1.7981217569350742e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE2,Glia-derived nexin,22239,1578,1.10 [1.03-1.18],0.0053864261283853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF1,Pigment epithelium-derived factor,21942,1560,1.38 [1.16-1.65],0.0003183509465612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF2,Alpha-2-antiplasmin,21862,1557,0.52 [0.37-0.74],0.0002723219788971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPING1,Plasma protease C1 inhibitor,22222,1587,2.25 [1.75-2.89],1.9556944283208438e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINH1,Serpin H1,21824,1552,1.05 [1.01-1.09],0.019399526805259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SETMAR,Histone-lysine N-methyltransferase SETMAR,25366,1768,1.17 [1.02-1.33],0.0208531250543602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L,Seizure 6-like protein,25671,1804,0.82 [0.71-0.95],0.0073871042937831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP1,Secreted frizzled-related protein 1,25354,1770,1.21 [1.10-1.33],0.0001066044650759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP4,Secreted frizzled-related protein 4,21736,1552,0.83 [0.74-0.93],0.0021756539450149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,24989,1767,1.19 [1.12-1.27],7.42908884276126e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,24989,1767,1.55 [1.46-1.64],1.912134058703543e-52
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,25613,1801,1.17 [1.10-1.25],2.064391941778421e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,21896,1539,1.23 [1.13-1.33],7.547913258675982e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2B3,SH2B adapter protein 3,24989,1767,1.06 [1.01-1.10],0.0159160376553745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2D1A,SH2 domain-containing protein 1A,25598,1805,1.07 [1.00-1.14],0.0425461401375109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,22235,1580,2.14 [1.80-2.53],1.8974645682497096e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,25625,1801,1.23 [1.13-1.34],2.198938944396012e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,25724,1819,1.41 [1.29-1.55],6.65880655027953e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,25598,1805,1.34 [1.19-1.52],3.605695375620004e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,25852,1817,1.16 [1.03-1.31],0.0141144154989195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,25613,1801,2.15 [1.86-2.48],1.5313698513813934e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,21631,1536,1.36 [1.22-1.51],1.9986137520091532e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,25820,1812,1.25 [1.10-1.44],0.0009676172303139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIL1,Nucleotide exchange factor SIL1,21631,1536,1.17 [1.03-1.34],0.0137284272969811
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,25671,1809,1.09 [1.02-1.18],0.0169778109098421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,25545,1811,1.29 [1.18-1.41],1.779405207114018e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,25143,1785,1.24 [1.16-1.33],1.029708232554459e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP1,Src kinase-associated phosphoprotein 1,25405,1777,1.13 [1.07-1.19],1.161210635090106e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,25143,1785,1.17 [1.09-1.27],2.428833932656852e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF6,SLAM family member 6,24989,1767,1.20 [1.08-1.35],0.0009773154409113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF7,SLAM family member 7,25598,1805,1.15 [1.08-1.23],5.160554077866239e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,24989,1767,1.25 [1.15-1.36],3.467417093214081e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC16A1,Monocarboxylate transporter 1,25026,1760,1.10 [1.04-1.17],0.0019999473682494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A14,Zinc transporter ZIP14,25026,1760,1.16 [1.02-1.31],0.0211004431113329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A5,Zinc transporter ZIP5,25598,1805,1.13 [1.06-1.21],0.0001836618539783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC4A1,Band 3 anion transport protein,22235,1580,0.89 [0.81-0.99],0.0249196883672278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIT2,Slit homolog 2 protein,25026,1760,1.10 [1.02-1.19],0.0164988646843213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,21601,1534,0.53 [0.45-0.61],1.2889169587203483e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,25852,1817,0.68 [0.62-0.75],7.896610261414833e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD1,Mothers against decapentaplegic homolog 1,24989,1767,1.07 [1.02-1.12],0.0051166254420534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD5,Mothers against decapentaplegic homolog 5,25512,1792,1.87 [1.49-2.34],5.819458601257925e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMARCA2,Probable global transcription activator SNF2L2,25026,1760,1.06 [1.00-1.12],0.0370275032428468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,22149,1572,1.10 [1.04-1.17],0.0017151126665319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,25852,1817,1.39 [1.23-1.58],1.3839666345826694e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,25724,1819,1.31 [1.18-1.46],6.279222236814075e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,25741,1802,1.45 [1.35-1.55],1.0051879196460531e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,25676,1817,1.19 [1.12-1.27],5.339629603340728e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMTN,Smoothelin,22120,1566,1.08 [1.03-1.13],0.0021950321567948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP29,Synaptosomal-associated protein 29,25671,1804,1.05 [1.01-1.10],0.026631474367745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',22173,1569,1.15 [1.07-1.24],0.0001445683671339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",25606,1800,1.42 [1.28-1.57],1.792561984546791e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,22205,1573,1.13 [1.02-1.26],0.019721333826572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,24989,1767,1.39 [1.25-1.56],2.8859167083490235e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORT1,Sortilin,25581,1799,1.28 [1.15-1.42],4.908312124245585e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOST,Sclerostin,25581,1799,1.15 [1.03-1.28],0.0130720760820272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARC,SPARC,25671,1804,1.16 [1.09-1.24],1.010147288834048e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,25606,1800,1.62 [1.49-1.76],4.5725385575242114e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,21736,1552,1.32 [1.16-1.51],2.588360986772149e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,25598,1805,1.16 [1.09-1.24],4.116865724706361e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,25852,1817,1.24 [1.14-1.33],7.834960719669848e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,25516,1795,1.89 [1.64-2.19],8.169947815539335e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,25724,1819,1.27 [1.15-1.41],2.792837867123576e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT3,Kunitz-type protease inhibitor 3,22149,1572,0.95 [0.92-0.98],0.0008229669233933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,25638,1816,1.87 [1.65-2.11],1.3648797413744356e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,25486,1791,1.65 [1.47-1.86],6.913028645215833e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPP1,Osteopontin,25880,1825,1.27 [1.16-1.38],1.2121626992855914e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR3,Small proline-rich protein 3,22173,1569,1.11 [1.03-1.20],0.0047208436904727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRP14,Signal recognition particle 14 kDa protein,25512,1792,1.10 [1.03-1.17],0.0041297341606021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPK2,SRSF protein kinase 2,25598,1805,1.06 [1.01-1.11],0.0195824162900064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,22239,1578,1.25 [1.08-1.44],0.0026267950628777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,25581,1799,0.88 [0.85-0.91],8.179743761319393e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,25691,1811,1.20 [1.09-1.32],0.0001323455699522
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",25930,1825,1.77 [1.55-2.03],8.101869724598702e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAB2,Stabilin-2,22235,1580,1.44 [1.22-1.69],1.6978412708210647e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC1,Stanniocalcin-1,25866,1814,1.27 [1.16-1.38],7.076651453859152e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC2,Stanniocalcin-2,25573,1795,1.20 [1.02-1.41],0.0300427526676783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX8,Syntaxin-8,25598,1805,1.12 [1.04-1.22],0.003900911909057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,25598,1805,1.24 [1.17-1.32],1.119579350505794e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,25866,1814,1.15 [1.06-1.25],0.0005357023159416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,25606,1800,1.97 [1.80-2.16],6.243789283470447e-47
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD4,Sushi domain-containing protein 4,22130,1568,0.84 [0.75-0.95],0.0043836720565737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD5,Sushi domain-containing protein 5,21626,1548,0.80 [0.69-0.91],0.0012369599847587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SWAP70,Switch-associated protein 70,22149,1572,1.18 [1.04-1.34],0.0089049741690273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TADA3,Transcriptional adapter 3,22130,1568,1.14 [1.01-1.28],0.0346963945162389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,25512,1792,1.42 [1.26-1.59],3.927243396763881e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TALDO1,Transaldolase,22166,1577,1.13 [1.03-1.24],0.0133511645212371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",22130,1568,0.87 [0.76-1.00],0.0474139754090627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAX1BP1,Tax1-binding protein 1,22173,1569,1.10 [1.02-1.18],0.0126738558153231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN2,Transcobalamin-2,25880,1825,1.30 [1.13-1.50],0.0001975928073799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCOF1,Treacle protein,22239,1578,1.28 [1.13-1.44],6.885627191469556e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,22239,1578,1.48 [1.27-1.73],4.410480736265584e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TET2,Methylcytosine dioxygenase TET2,21791,1549,1.05 [1.01-1.10],0.0191929139764232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TF,Serotransferrin,22268,1588,1.34 [1.07-1.68],0.0102946441478993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,25489,1794,1.29 [1.23-1.35],1.5530473329113628e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,25685,1817,1.60 [1.51-1.70],1.6485615947903455e-55
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,25579,1801,1.33 [1.23-1.44],3.4929178630229534e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI,Tissue factor pathway inhibitor,25522,1799,1.35 [1.22-1.50],8.750146233648922e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,25585,1798,1.29 [1.18-1.40],7.516428912713131e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,25598,1805,1.43 [1.33-1.53],5.25808489309784e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,25873,1818,1.42 [1.28-1.57],9.308050101860926e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBI,Transforming growth factor-beta-induced protein ig-h3,25442,1794,1.34 [1.15-1.56],0.0002142801257686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR1,TGF-beta receptor type-1,21601,1534,1.27 [1.01-1.60],0.0428097791151687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,25671,1804,1.57 [1.39-1.77],2.0270936848694277e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,25930,1825,1.20 [1.05-1.37],0.0085358319989029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,22256,1575,1.29 [1.06-1.56],0.0099923634494724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBD,Thrombomodulin,25613,1801,1.30 [1.12-1.52],0.0007903077045834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,25606,1800,1.49 [1.34-1.66],2.43538991158876e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THOP1,Thimet oligopeptidase,25506,1797,1.40 [1.23-1.58],1.121028595165858e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THPO,Thrombopoietin,25161,1772,1.17 [1.05-1.30],0.004155174278686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THSD1,Thrombospondin type-1 domain-containing protein 1,21437,1523,0.82 [0.70-0.95],0.0083017340657488
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIE1,Tyrosine-protein kinase receptor Tie-1,25930,1825,1.20 [1.08-1.33],0.0004681751765302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",24980,1759,1.10 [1.01-1.20],0.0353494219026695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,21824,1552,1.21 [1.06-1.38],0.0045471902434356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,25691,1811,1.24 [1.13-1.36],4.3671719381280205e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,25316,1783,2.03 [1.76-2.34],5.2624622206093763e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP3,Metalloproteinase inhibitor 3,25724,1819,1.05 [1.02-1.08],0.0009330462578687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,25606,1800,1.57 [1.43-1.72],1.752422602439548e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,25534,1797,0.79 [0.66-0.95],0.0135709710476068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,22125,1564,1.41 [1.24-1.59],1.2489629531223717e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS15,Enteropeptidase,25512,1792,1.05 [1.00-1.10],0.0300747789140594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMSB10,Thymosin beta-10,25606,1800,1.13 [1.07-1.19],1.7116436111803873e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNC,Tenascin,25691,1811,1.18 [1.08-1.29],0.0002651358501463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNF,Tumor necrosis factor,25120,1767,1.24 [1.14-1.36],8.583760844445097e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,22149,1572,1.13 [1.04-1.22],0.0022119767893604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,25451,1778,1.94 [1.72-2.18],1.2953075670191414e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,25451,1778,1.68 [1.63-1.73],6.819359434609546e-254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,25658,1813,1.18 [1.08-1.28],0.00012979134457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,25921,1826,1.39 [1.25-1.54],1.7518553130069303e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,25593,1813,1.77 [1.57-1.99],2.222299483482012e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,25671,1804,1.75 [1.57-1.95],7.812120173844395e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,25638,1816,1.48 [1.34-1.64],1.195279801256944e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,25638,1816,1.66 [1.45-1.89],3.627495495145321e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,25852,1817,1.27 [1.11-1.45],0.0005177442094045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,25606,1800,2.01 [1.77-2.29],1.1281556348403836e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,25606,1800,1.49 [1.39-1.60],1.0889879483624632e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,25866,1814,1.41 [1.22-1.63],4.433788322669073e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,25873,1818,1.39 [1.24-1.56],1.2755387918347677e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,25451,1778,1.48 [1.40-1.58],5.432329737836249e-37
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,25866,1814,1.12 [1.02-1.23],0.0182527971826412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,25451,1778,1.42 [1.29-1.57],2.5410115846437288e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,25598,1805,0.85 [0.80-0.91],7.894560837783651e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,25921,1826,0.82 [0.71-0.94],0.0040381162771966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,25724,1819,1.80 [1.56-2.08],5.958784598844303e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,25880,1821,1.87 [1.64-2.14],1.591268052785523e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,25451,1778,1.16 [1.08-1.24],2.2801715940507875e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNIP1,TNFAIP3-interacting protein 1,22173,1569,1.07 [1.01-1.13],0.0143790133354961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNN,Tenascin-N,22235,1580,0.82 [0.73-0.92],0.000721169943622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,25451,1778,0.65 [0.59-0.71],8.612909433345474e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNXB,Tenascin-X,25606,1800,1.17 [1.00-1.37],0.0447216578851617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,22239,1578,1.07 [1.01-1.14],0.028209473100734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1,DNA topoisomerase 1,22149,1572,0.93 [0.89-0.97],0.0012653258678284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53BP1,TP53-binding protein 1,21601,1534,0.91 [0.86-0.97],0.0040589917639248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53I3,Quinone oxidoreductase PIG3,21265,1512,1.11 [1.01-1.21],0.0233547742316754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPK1,Thiamin pyrophosphokinase 1,22239,1578,1.36 [1.17-1.58],6.067690277266792e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,25430,1804,1.46 [1.37-1.56],2.0833406080178203e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,25593,1813,1.68 [1.57-1.80],2.673499914002664e-51
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,25852,1817,1.13 [1.06-1.21],0.0001908203282885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSHB,Thyrotropin subunit beta,25613,1801,0.89 [0.84-0.94],3.2521875677754486e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN7,Tetraspanin-7,21521,1528,0.93 [0.87-0.99],0.0177041940632864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN8,Tetraspanin-8,22149,1572,1.11 [1.06-1.17],2.7752160429872835e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXLNA,Alpha-taxilin,25451,1778,1.06 [1.01-1.12],0.0114116798361304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,25671,1804,1.42 [1.22-1.64],2.75873891897966e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,25866,1814,1.10 [1.04-1.17],0.0007823277876189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNL1,Thioredoxin-like protein 1,21482,1526,0.93 [0.87-1.00],0.0403038552882979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYMP,Thymidine phosphorylase,25451,1786,1.11 [1.05-1.18],0.0006646916820819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",21601,1534,1.10 [1.02-1.19],0.0187521198745541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,22239,1578,1.12 [1.04-1.21],0.0038829850064114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,25451,1778,1.46 [1.31-1.62],3.401309302420776e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,25839,1817,0.79 [0.74-0.86],1.0860223340929639e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNC5D,Netrin receptor UNC5D,21601,1534,0.79 [0.65-0.96],0.0158406738274063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPB1,Beta-ureidopropionase,22239,1578,1.09 [1.03-1.14],0.0010180818357244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UXS1,UDP-glucuronic acid decarboxylase 1,24989,1767,1.11 [1.02-1.21],0.0123881968719635
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,25161,1772,1.16 [1.08-1.26],0.0001367120474501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,25512,1792,0.78 [0.63-0.96],0.0167676300735825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAN,Versican core protein,25866,1814,1.20 [1.05-1.37],0.0068321236535061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,25832,1820,1.27 [1.19-1.35],2.080294804716735e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFC,Vascular endothelial growth factor C,25671,1804,1.13 [1.05-1.22],0.0008675277816829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFD,Vascular endothelial growth factor D,25874,1824,1.37 [1.22-1.54],8.88962754818207e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIT,Vitrin,22239,1578,1.43 [1.26-1.64],7.537435053232223e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,25512,1792,1.10 [1.03-1.17],0.0043710277487738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN1,Pantetheinase,22256,1575,1.09 [1.02-1.16],0.0160368778757361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,25512,1792,1.22 [1.11-1.33],1.154746766410722e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,21528,1521,1.28 [1.11-1.47],0.0004717513517012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,22130,1568,1.47 [1.36-1.59],1.0215858959495666e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,25573,1795,1.69 [1.52-1.87],2.175116793932009e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,25581,1797,1.07 [1.01-1.14],0.0244953552422138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSNL1,Visinin-like protein 1,22173,1569,1.22 [1.10-1.36],0.0001384382902483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,25026,1760,1.12 [1.03-1.22],0.0083184043286199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,25161,1772,1.10 [1.03-1.18],0.0057361770528017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,25822,1816,1.64 [1.50-1.79],6.880244141611295e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2,Brorin,25357,1772,1.35 [1.21-1.49],1.982350695509412e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",25606,1800,1.32 [1.18-1.48],1.1090042301127388e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASL,Neural Wiskott-Aldrich syndrome protein,21601,1534,0.88 [0.80-0.96],0.0053381959145634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC1,WAP four-disulfide core domain protein 1,21683,1543,1.15 [1.05-1.27],0.0037630442615901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,25802,1812,1.18 [1.11-1.26],3.923966038032804e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,24291,1694,2.01 [1.84-2.20],2.200750095018223e-52
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",25366,1768,0.66 [0.60-0.73],1.220889097748143e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",25638,1816,0.81 [0.72-0.92],0.0007845414319752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WIF1,Wnt inhibitory factor 1,25852,1817,1.39 [1.24-1.56],1.262570022071382e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WNT9A,Protein Wnt-9a,25143,1785,1.21 [1.06-1.39],0.0045284335405922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XCL1,Lymphotactin,25852,1817,1.18 [1.10-1.28],7.257227163729271e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XG,Glycoprotein Xg,25793,1815,1.16 [1.01-1.34],0.0413966747130413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XRCC4,DNA repair protein XRCC4,25026,1760,1.12 [1.00-1.25],0.0492175443952648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,22173,1569,1.95 [1.64-2.32],4.0643361929298295e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YES1,Tyrosine-protein kinase Yes,25512,1792,1.04 [1.01-1.08],0.0254675306385009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YTHDF3,YTH domain-containing family protein 3,25143,1785,1.06 [1.01-1.11],0.025720319101703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,25161,1772,1.19 [1.09-1.29],0.0001035832522807
